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HUMAN RIGHTS AND 
PEOPLE WHO USE DRUGS IN 
THE MEDITERRANEAN REGION: 
CURRENT SITUATION IN 
17 MEDNET COUNTRIES
The Council of Europe is the continent’s leading 
human rights organisation. It comprises 47 member 
states, including all members of the European 
Union. All Council of Europe member states have 
signed up to the European Convention on Human 
Rights, a treaty designed to protect human rights, 
democracy and the rule of law. The European Court 
of Human Rights oversees the implementation 
of the Convention in the member states.
For the first time, the Mediterranean Network for cooperation on 
drugs and addictions of the Pompidou Group discussed human 
rights. This started with a first literature research covering different 
topics. Among them, the consideration of drug use as a disease for 
developing drug policy, the right to access to care and treatment as 
a fundamental right for people who use drugs, the implementation 
of evidence-based prevention practices and health strategies, the 
fight against stigma and the needed adaptation of the law to a 
human rights approach. 
Research was carried out among the 17 MedNET countries (Algeria, 
Croatia, Cyprus, Egypt, France, Greece, Italy, Jordan, Lebanon, 
Malta, Morocco, Palestine*, Portugal, Spain, Switzerland, Tunisia 
and Turkey). Better understanding the meaning of human rights in 
drug policy and exchange best practices and ideas on this subject, 
was the objective of this first exercise, to be repeated.
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Pompidou Group 
T he Pompidou Group provides a multi-disciplinary forum at the wider European level where it is possible for policymakers, professionals and 
researchers to exchange experiences and information 
on drug use and drug trafficking. Formed at the sug-
gestion of the French President Georges Pompidou 
in 1971, it has become a Council of Europe partial 
agreement in 1980. In 2019, it gathers 39 countries: 
36 of the 47 member States of the Council of Europe, 
Mexico, Morocco and Israel, as well as the European 
Commission.
MedNET
M edNET is the Mediterranean network for co-operation on drugs and addictions of the 
Pompidou Group. MedNET is a permanent activity 
within Pompidou Group work programme. 
It promotes cooperation, exchange and mutual trans-
fer of knowledge between countries from both sides 
of the Mediterranean, respecting human rights and 
gender equality. It was created in 2006, after a feasi-
bility study carried out at the initiative of France and 
the Netherlands. The group was assessed positively 
and has developed ever since, geographically and 
thematically, to promote effective and appropriate 
answers. Its terms of reference are adopted within the 
framework of the Pompidou Group Work Programme.
The network consists of seventeen countries: Algeria, 
Croatia, Cyprus, Egypt, France, Greece, Italy, Jordan, 
Lebanon, Malta, Morocco, Palestine1, Portugal, Tunisia, 
Turkey and since 2019 Spain and Switzerland. 10 
countries are Pompidou Group members and 7 are not.
The European Commission and the European 
Monitoring Centre for drugs and drugs addictions 
(EMCDDA) participate as observers to the meetings. 
1. This designation shall not be construed as recognition of a 
State of Palestine and is without prejudice to the individual 
positions of Council of Europe member States on this issue.
Since 2006, MedNET countries have worked together 
to initiate and conduct ambitious projects. To ensure 
their success, they are based on South-South, North-
South and South-North cooperation. The MedNET 
network aims to promote interaction between policy, 
practice and science, to adapt their implementation 
to the context of different countries. 
The question of addictive behaviours represents a 
central issue for our societies and calls for a global 
answer taking into account Human Rights combin-
ing prevention, health, fight against drug trafficking, 
law enforcement, as well as training and research. It is 
therefore crucial to develop a dynamic cooperation, to 
include civil society, which reflects the commitment 
taken by all members of the network. 
This document provides the information available 
(for European countries, the sources are generally 
EMCDDA reports) and supplementary information 
from the respective 17 MedNET countries: Algeria, 
Croatia, Cyprus, France, Lebanon, Malta, Morocco, 
Palestine*, Portugal, Spain, Switzerland, and 
Tunisia. 
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Background
I n view of the discussion on “Human rights and people who use drugs in MedNET countries: current situation, challenges and future” which 
took place during the 25th MedNET meeting on 19 
November 2019 – chaired by Prof. Nabil BEN SALAH 
– the Pompidou Group Secretariat conducted a first 
research on this topic among the 17 MedNET countries. 
Prof. Jallal TOUFIQ, MedNET Representative of 
Morocco, who proposed the topic and facilitated 
this discussion, underlined the following items to 
undertake the research: 
Human rights approach for people who use drugs should 
concern every single dimension related to drug use: 
 ► Health approach at the policy level: drug use 
must be considered rightly as a medical con-
dition to be taken care of by qualified health 
professionals;
 ► Treatment must be available, accessible, afford-
able and science-based, with the best practices;
 ► Prevention must be based on science, facts and 
best practices;
 ► Data collection must be considered as a part 
of the right to access information for the com-
munity and the professionals;
 ► Rehabilitation and social reintegration must 
be provided;
 ► Access to treatment and care for specific pop-
ulations must be available: people who use 
drugs in prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.;
 ► Fight against stigma and raising awareness in 
the society as a whole is needed; 
 ► The adaptation of the law to the human rights 
approach especially for minors and non-traf-
ficking users;
 ► Promoting the right of people who use drugs 
to create their own NGOs and self-help groups;
 ► Promoting the right to access treatment for all 
the consequences of drug use;
 ► Promoting every strategy aiming at reducing 
the health, economic, social and legal conse-
quences of drug use.
In the country research, the rationale was to find 
information on the above-mentioned topics. The 
results presented are not intended to be exhaustive 
but to provide an overview. 
The main objective of this discussion was to better 
understand the meaning of human rights in drug 
policy and to exchange best practices and ideas 
on this subject.
This objective was consistent with the November 
2018 “Stavanger Declaration” of the Pompidou Group’s 
Ministerial Conference which reaffirms a focus on 
“human rights as a fundamental cornerstone in 
drug policy”, in line with the Council of Europe’s 
core mission.
We want to give a special note of thanks to all 
the MedNET Representatives who replied to our 
request for information (response rate: 70%): 
 ► For Algeria: Mr. Mohammed BENHALLA, 
General Director of the National Office for the 
Fight against Drug Abuse and Drug Addiction 
(ONLCDT); 
 ► For Croatia: Mr. Željko PETKOVIĆ, Head of the 
Office for Combating Drugs Abuse Government 
of the Republic of Croatia; 
 ► For Cyprus: Ms. Leda CHRISTODOULOU, Officer 
in the Policy Department of Cyprus National 
Addictions Authority;
 ► For France: Ms. Laura D’ARRIGO, Diplomatic 
Counsellor for the Interministerial Mission for 
Combating Drugs and Addictive Behaviours 
(MILDECA); 
 ► For Italy: Dr. Elisabetta SIMEONI, General 
Director, Head of technical Scientific & general 
Affairs office, Presidency of the Committee of 
Ministers, Department for Anti-drug Policies; 
 ► For Lebanon: Prof. Ramzi HADDAD, Head of 
Department of Psychiatry, Lebanese University, 
Co-Founder of Skoun, Lebanese Addictions 
Centre;
 ► For Malta: Prof. Marilyn CLARK, Department 
of Psychology Faculty for Social Wellbeing, 
University of Malta, MSC Addiction Studies 
Course Coordinator and President of Malta 
Chamber of Psychologists; 
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 ► For Morocco: Prof. Jallal TOUFIQ, Director of 
the Ar-razi University Psychiatric Hospital & the 
National Center on Drug Abuse Prevention, 
Treatment and Research, Director of the 
National Observatory on Drugs and Addictions; 
 ► For Palestine*: Mrs. Maria Yousef AL-AQRA, 
Director of International Cooperation, 
Palestinian Ministry of Health & Dr. Saed 
BALIBISI, Acting Director of Methadone Center, 
Palestinian Ministry of Health; 
 ► For Portugal: Ms. Sofia SANTOS, Head of 
International Relations Division, Head of 
Portuguese Focal Point to the EMCDDA, General-
Directorate for Intervention on Addictive 
Behaviours and Dependencies (SICAD); 
 ► For Spain: Ms. Elena ALVAREZ MARTIN, Deputy 
Director of Institutional Relations, Government 
Delegation for the National Plan on Drugs, 
Ministry of Health, Consumer Affairs & Social 
Welfare; 
 ► For Switzerland: Ms. Diane STEBER BÜCHLI, 
Federal Department of Home Affairs, Federal 
Office of Public Health, Divisions of International 
Affairs; 
 ► For Tunisia: Prof. Nabil BEN SALAH, Director 
General of the Anti-Poisons and Emergency 
Medical Assistance Centre, President of the 
Tunisian Society of Addictology, President of 
the Subcommittee on Addictions of the National 
Mental Health Commission. 
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Algeria
T he main source of information for this country is the Council of Europe 2014 Report “Algeria: Drug Situation and Policy2”: any information not 
quoted as coming from another source is considered 
to come from this report. The MedNET Representative 
of Algeria, Mr. Mohammed BENHALLA, made com-
ments in italics. 
Health approach at the policy level: drug 
use being considered rightly  
as a medical condition to be taken care by 
qualified health professionals 
Algerian Law No. 04-18 regards drug addiction as an 
illness that needs to be treated. 
“Treatment orders as an alternative to imprisonment 
for cases of drug addiction” provided for in Algerian 
Law No. 04-18 constitute a step towards treating drug 
use as a medical condition.
Law No. 04-18 on the “Prevention and punishment of the 
illicit use and trafficking of narcotic drugs and psycho-
tropic substances” of 25 December 2004 is a key stage 
in the change of status of individuals [who use] drugs, 
which has shifted from them being seen as criminals 
to be punished to regarding them as people who are ill 
and in need of treatment. The law places the emphasis 
on court-ordered treatment as an alternative care and 
prevention measure to a criminal-law response. It thus 
represents a significant change in Algerian legislation 
towards regarding drug addiction as an illness, as it is 
the case in many countries. 
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
According to a report made by the Council of Europe 
in 2011, Algerian Government started a multi-year 
programme in 2007 to set up a widespread network 
of centres to treat and take care of persons who use 
drugs in the different regions of the country. 
Residential treatment programs include reception 
and counselling; motivational interviewing; evalua-
tion of the most problematic patterns of use: starting 
young, combining drugs, overdosing, repetitive use; 
2. Council of Europe, “Algeria: Drug situation and policy”, 2014, 
48 p. Ref: P-PG/MedNET (2014) 6. Available online: https://
rm.coe.int/drug-situation-and-policy-by-salah-abdennouri-
former-general-director-/168075f0e3.
risk factors: personality traits, risk-taking behaviour, 
context in terms of school, family, environment, etc.
A number of Algerian doctors have also taken part 
in the training on substitution treatment organised 
by the Pompidou Group in various countries of the 
region in the context of MedNET activities.
Algeria is in the process of introducing opioid substi-
tution treatment (OST) in its health programme. To 
that end, a care centre for drug addiction has been 
selected and a molecule is in the process of being 
registered with the General Directorate of Pharmacy. 
Ongoing implementation of the 2007 programme 
established by the Ministry of Health, 43 intermediate 
care centres out of the 53 planned and 2 treatment 
centres for drug addiction out of the 15 planned are 
operational.
Ongoing efforts are made by the health sector in the 
following areas:
 ► Information and awareness rising about social 
ills including drugs are part of the activities car-
ried out by the screening and monitoring units, 
in co-ordination with the Ministry of Education; 
 ► Ongoing in-service training scheme for profes-
sionals involved in combating addiction;
 ► A certificate of specialised studies in addictology 
was launched in 2017 for the benefit of over 40 
intermediate care centres doctors in the Algiers 
and Blida medical schools – the first batch of 
students graduated in September 2018;
 ► Ongoing efforts to provide health care for 
[people who use drugs] seeking treatment: 
the number of people helped rose from 21 507 
in 2016 to 22 444 in 2017.
The National Strategy for Combating STI/HIV/AIDS 
includes:
 ► Integrating intravenous drug users among the 
priority target groups classed as vulnerable or 
at high risk of exposure to HIV;
 ► Developing measures to prevent and reduce the 
risk of STI/HIV/AIDS among this section of the 
population with a view to encouraging them 
to adopt less risky behaviours.
Prevention must be based on science, 
facts and best practices 
The National Strategic Plan in Algeria focuses on 
prevention strategies and urges all players to base 
their activities on information, education and 
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communication. Training courses are also available 
relating to the prevention and combating of drug 
abuse and drug addiction in Algeria, though it is noted 
they have limited funding.
Epidemiology survey on drugs in university settings: 
 ► The development of the new Strategy for 
Combating Drugs and Drug Addiction 2020-
2024, final Report December 2019;
 ► Setting-up within the Office’s Evaluation and 
Monitoring Committee of a sub-committee 
responsible for “preventing addiction in schools 
and among young people”;
 ► Setting-up within the Office’s Evaluation 
and Monitoring Committee of a second sub-
committee responsible for “preventing addic-
tion among vulnerable groups (women and 
children)”;
 ► The Office helped to send senior officials from 
the General Directorate of Customs and doctors 
specialising in drug addiction to attend training 
courses abroad.
Data collection as a part of the right to 
access information for the community 
and the professionals
The National Office for the Fight against Drug Abuse 
and Drug Addiction centralizes information and figures 
relating to the prevention and punishment of drug 
use and the treatment of people who use drugs. Its 
annual reports contain statistics relating to seizures of 
drugs, the ways in which the courts deal with offences 
against drug regulations and legislation, and the treat-
ment of drug addicts. The National Statistics Office 
disseminates information available to the public.
The Office acts as a receptacle for data from various sec-
tors such as: Ministry of Justice, Ministry of Health, the 
General Directorate of National Security, the National 
Gendarmerie, the customs authorities, etc. and sees to 
it that they are processed.
Rehabilitation and social reintegration
Goals of the National Commission for the Fight 
against Drug Abuse and Drug Addiction include: to 
initiate, organise and take part in training or informa-
tion seminars on the fight against illegal trafficking 
and abuse of narcotics and psychotropic substances 
and on the treatment or rehabilitation of people 
who use drugs.
Reintegration and rehabilitation arrangements exist 
in Algeria for former prisoners with drug-related 
problems.  
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc. 
Health Ministry [created] and opened treatment cen-
tres as planned under the 2007 project in order to 
improve the system of care and treatment for people 
who use drugs.
 ► Treatment and rehabilitation facilities for [people 
who use drugs] are constantly assessed by the 
authorities;
 ► Detoxification centres are located in hospitals 
and are overseen by qualified personnel (doctors, 
psychologists, etc.) as well as civil society actors;
 ► To prevent infectious diseases, various services 
are provided by the Ministry of Health for [people 
who use drugs], including prisoners;
 ► Inmates [who use drugs] in penal institutions are 
cared for in such a way as to preserve their dignity 
and physical integrity;
 ► Health care and treatment for [people who use 
drugs] are provided free of charge.       
Fight against stigma and raising 
awareness in the society as a whole
The National Strategic Plan (Office) has since its incep-
tion constantly carried out information and awareness-
raising activities, periodically holding local conferences 
and seminars to raise awareness among local officials 
and residents of the dangers of drug use, and to get 
society as a whole working against it.
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
Law No. 04-18 is a comprehensive law, insofar as it 
deals with drug abuse and drug addiction in terms 
of both prevention and punishment, and with regard 
to drug addiction, it makes a distinction between 
the victims and the criminals and provides for the 
waiving of court proceedings for those who agree 
to undergo medical treatment. It also introduces 
compulsory treatment.
Additionally, provisions of Articles 6 to 11 actually deal 
with the ending of the criminal prosecution of people 
who use drugs, if they, as ordered by the responsible 
court, undergo curative and detoxification treatment 
at specialized establishments.
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Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
Also to be mentioned are the operations to strengthen 
capacities organized in partnership with the Pompidou 
Group between 2005 and 2010, particularly the 
sequence of training activities for doctors on work-
ing with people with substance use disorder (SUD) (in 
the context of implementation of the multi-annual 
national program to strengthen drug addict treatment 
and care facilities).
Various capacity-building activities were conducted, 
including notably the following training exercises:
 ► A training seminar organised in co-ordination 
with the Pompidou Group, on the theme “New 
approaches to prevention”;
 ► A training seminar organised in co-ordination 
with the UNODC on school-based prevention.
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
Harm reduction methods in Algeria focus on addic-
tion prevention measures, as well as treatment and 
rehabilitation measures for people who use drugs.
One of the goals of the National Strategic Plan against 
STDs/HIV/AIDS was to achieve universal access to 
prevention, diagnosis, treatment and care.
The National Strategic Plan to combat STDs and HIV/
AIDS 2016-2020 aims:
 ► To reduce the number of new HIV infections to 
less than 500 new infections per year;
 ► To stabilise HIV-specific mortality at less than 5%;
 ► To reduce mother-to-child transmission of HIV 
to less than 5%;
 ► To keep 90% of HIV-positive mothers and children 
alive.
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
The treatment of [people who use drugs] addresses 
their personality and their relationship with drugs, 
their social situation and the consequences of their 
drug use.

 ► Page 13
Croatia
T he main source of information for this country is the EMCDDA 2019 Report “Croatia: Country Drug Report 20193”: any information not quoted 
as coming from another source is considered to 
come from this report. The MedNET Representative 
of Croatia, Mr. Željko PETKOVIĆ, made comments in 
italics. 
Health approach at the policy level: drug 
use being considered rightly as a medical 
condition to be taken by qualified care 
health professionals 
The 2012-17 Strategy sought to reduce both the 
demand for and the supply of drugs in society, while 
protecting the health of individuals, families and 
communities through an integrated and balanced 
approach to drug problems.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
Treatment is available often through primary health-
care and outpatient facilities, as well as some impatient 
and therapeutic communities. Outpatient services 
promote mental health practices as well as utilize 
science-based methods including OST, psychotherapy, 
medication-based treatment, detoxification, drug-free 
programs, and individual and group psychosocial 
treatment.
In the Republic of Croatia, treatment of [people who use 
drugs] is primarily conducted in the health care system, 
and certain forms of psychosocial treatment are also 
conducted in the social welfare system, therapeutic 
communities and associations, as well as in the prison 
and probation systems. In addition, treatment of [people 
who use drugs] who are minors or young adults, as well 
as occasional alcohol and is also conducted in homes for 
children without adequate parental care, and children 
and youth with behavioural disorders. 
Treatment of people who use drugs or people with sub-
stance use disorders (SUD) within the health care system 
is divided into inpatient and outpatient treatment.
 ► Treatment within the inpatient system is provided 
for [people who use drugs] and persons wishing to 
3. European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), “Croatia: Country Drug Report 2019”. 
Available online: http://www.emcdda.europa.eu/countries/
drug-reports/2019/croatia_en. 
initiate abstinence, but having significant physi-
cal and mental comorbidities, as well as social 
problems (accommodation).
 ► However, outpatient treatment is the main type 
of drug addiction treatment in Croatia: it is con-
ducted by services for mental health protection, 
addiction prevention and outpatient treatment 
of county institutes of public health. In order to 
enter outpatient treatment a person does not 
need to present the Service with a referral letter, 
but they only need to have a regulated right to 
health care in the Republic of Croatia. This is 
provided for all [people who use drugs] under the 
2002 Ordinance. The above Ordinance provides 
the right to health insurance to all [people who 
use drugs] treated in a health care institution or 
participating in the implementation of special 
measures for helping “[people who use drugs] in a 
therapeutic community or other organised forms 
of assistance (…) as long as these circumstances 
are in place.”
 It can therefore be said that addiction treatment in the 
Republic of Croatia is completely free of charge and 
that there is a low threshold for entering the treatment.
Prevention must be based on science, 
facts and best practices 
Environmental prevention methods are used in school 
settings in an effort to minimize drug use from a young 
age (including curfew hours).
Selective prevention is also a central focus for preven-
tion within Croatia, for example through programs 
targeting at risk communities of young people. As 
well as the MOVE Program, which provides education 
for experts, involved in providing counselling to young 
people with risky behaviour profiles. It comprises interac-
tive training in communication, based on the principles 
of motivational interviewing and the trans theoretical 
model of behaviour change.
The Republic of Croatia promotes prevention in accor-
dance with the European Quality Prevention Standards 
(EDPQS) and the International Standards for the 
Prevention of Drug Abuse (UNODC).
In the Republic of Croatia, universal prevention strategies 
are most often implemented in the school environment.
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Data collection as a part of the right to 
access information for the community 
and the professionals
The websites and libraries of the Ministry of Science 
and Education provide information on up to date 
research findings on drugs and health. In addition, 
funding and research agencies are another means 
for the spread and aim to make information more 
accessible. 
There is also a need to mention the Internet pages of the 
Croatian Institute of Public Health (www.hzjz.hr) and 
the Drug Abuse Service (www.drogeiovisnosti.gov.hr). 
Rehabilitation and social reintegration
Outpatient drug treatment is provided by some asso-
ciations that provide psychosocial treatment alongside 
social reintegration interventions and by units in 
general hospitals.
The services of outpatient treatment are primarily pro-
vided in the health care system, and certain forms of 
psychosocial treatment are also conducted in the social 
welfare system, therapeutic communities and associa-
tions, as well as in the probation system. As regards their 
organization and scope of work, the services combine the 
activities of health care, social protection and education 
with the aim to conduct continuous monitoring, educa-
tion, psychotherapy, family therapy, HIV and hepatitis 
infection prevention and provide assistance in solving 
other life issues of [people who use drugs] and their 
families, as well as to provide help to occasional [people 
who use drugs] and their families.
The services of outpatient treatment also provide sub-
stitution therapy and various forms of psychosocial 
treatment and psychosocial interventions, including 
interventions at the psychological level, such as sup-
portive psychotherapy, psycho education, behavioural 
psychotherapy, family psychotherapy, etc.
Since 2007 Croatia has been implemented Project of 
social reintegration of people with substance use disor-
ders (SUD), which encompasses interventions aimed at 
social inclusion of people with SUD into the community 
life upon completion of their treatment in a health care 
institution, withdrawal in a therapeutic community or 
prison sentence served in the prison system, including 
psychosocial support, completion of education, retrain-
ing and employment, assistance with the housing or 
organised housing of treated [people who us drugs], 
and other forms of social interventions aimed at inte-
grating as many [people who us drugs] into the society 
as possible. 
Projects to be provided by NGOs in the areas of 
prevention, re-socialization and harm reduction are 
funded by the Government. 
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc. 
Populations such as minors and young adults have 
access to treatment through the healthcare system. 
Youth populations, for example, with behavioural 
disorders or lack of parental guidance are provided 
with treatment as well as [people] in the prison and 
probation systems. 
Refugees/migrants, after being accommodated in 
Asylum Seekers’ Reception (in usually Zagreb or Kutina), 
are required to undergo an initial health examination, 
which is the first way of detecting potential abuse of 
psychoactive substances.
When refugees are identified, or when there is a suspicion 
on abuse of psychoactive substance, the competent 
medical practitioner at the Reception Centre (primary 
health care physician), in agreement with MDM physician 
(Doctors of the World) will determine further medical 
examinations and referral to the Service Public Health 
Institute, Andrija Štampar.
In the aforementioned City Public Health Institute, an 
analysis will be carried out to determine from which 
substances each refugee is addicted to. City Institute 
still prescribed the necessary treatment. 
Psychosocial support to refuges with addiction problems 
is provided by a psychologist (Doctors of the World) who 
takes care of regularity of taking therapy and individual 
and group therapy with addicts.
Fight against stigma and raising 
awareness in the society as a whole
Croatia has full provision on information days about 
drugs as well as extensive provision on promoting 
social and personal skills and events for parents. 
The International Day Against Drug Abuse and Month 
for Combating Drug Addiction are [also] celebrated in 
the Republic of Croatia.
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
The Criminal Code urges the Court to use a number of 
alternative measures to imprisonment, such as fines, 
community service, probation and treatment, in cases 
in which a prison sentence of up to 6 months would 
otherwise be imposed. Compulsory drug treatment 
may be prescribed for up to 3 years, and time spent 
in treatment is taken into account when sentencing. 
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Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
A number of surveys estimating the prevalence of the 
use of illicit substances conducted with financial sup-
port from the Office for Combating Drug Abuse of the 
Government of the Republic of Croatia, the EMCDDA, the 
Croatian National Institute of Public Health, the Ministry 
of Health and other country, and local-level institutions.
The Republic of Croatia provides national funding for 
non-governmental organizations active in the field 
of combating drug abuse through annual tenders for 
lottery-funded projects. In 2018, 493 333 Euros was 
allocated for national NGO funding. Projects in the area 
of  prevention, re-socialization and harm reduction are 
funded. Former people who use drugs set up NGOs and 
self-help groups. Self-help groups operate nationwide 
through NGOs – Clubs of treated alcoholics for example. 
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
The right of access to treatment for all consequences of 
drug abuse is granted in the Republic of Croatia: stipu-
lated in National Strategy.
Harm reduction services include providing needles 
and syringes as well as other equipment utilized, and 
offer counselling and “voluntary, anonymous and free 
testing for infectious diseases (HIV, hepatitis C and 
hepatitis B); in active intravenous drug users, testing 
for infectious diseases is recommended twice a year4”. 
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
Croatia developed the Guidelines for drug-related harm 
reduction programs5 in 2015.
4. Office for Combating Drug Abuse (OCDA), “Guidelines for 
drug-related harm reduction programmes”. Available online: 
https://drogeiovisnosti.gov.hr/UserDocsImages//dokumenti/
Smjernice//GUIDELINES%20FOR%20DRUG-RELATED%20
HARM%20REDUCTION%20PROGRAMMES.docx. 
5. Ibidem.  
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Cyprus
T he main source of information for this country is the EMCDDA 2019 Report “Cyprus: Country Drug Report 20196”: any information not quoted as 
coming from another source is considered to come 
from this report. The MedNET Representative of Cyprus, 
Ms. Leda CHRISTODOULOU, made comments in italics. 
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken care of by 
qualified health professionals 
The National Strategy on Illicit Substances Dependence 
and the Harmful use of Alcohol 2013-2020 states that 
drug use and dependence should be addressed as a 
public health issue. It also highlights the principle that 
care must be equally accessible, readily available and of 
a certain level of quality for everyone in need.
Penalties for drug use can be extended to a lifetime 
sentence, though a life sentence has yet to be given 
out. Individuals found with possession for personal 
use can be given up to 12 years in prison. There are 
exceptions for some first-time offences as well as a 
Law in 2016 which allows accused to seek out alter-
native treatment.
Although in theory penalties for drug use in Cyprus could 
reach life imprisonment for all classes of drugs, it is impor-
tant to mention that this has never been implemented 
in practice. Possession for personal use is regarded as a 
serious criminal offence, punishable by up to 12 years 
in prison for class A drugs, eight years for class B and 
four years for class C; however, first-time offenders aged 
under 25 are usually not given sentences exceeding one 
year in prison.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
The National Strategy on Illicit Substances Dependence 
and the Harmful use of Alcohol and related Action Plan 
focus on making treatment more accessible. Other 
progress includes adding low threshold services to 
treatment centres, extending working hours of treat-
ment centres, new protocol referring soldiers to treat-
ment and introducing legislation for the provision of 
alternatives to incarceration.
6. European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), “Cyprus: Country Drug Report 2019”. 
Available online: http://www.emcdda.europa.eu/countries/
drug-reports/2019/cyprus_en. 
The treatment system includes specialized outpatient 
counselling and opioid substitution treatment (OST) 
centres, inpatient treatment, a therapeutic community 
and a residential treatment program. All counselling, 
outpatient and inpatient programs use psychosocial 
interventions as their primary treatment tool.
Treatment programs are offered by NGOs (non-profit), 
the public sector and a private party (for profit).
Goals of most treatment centres report abstinence, 
prevention of infectious diseases, development of 
self-awareness, self-esteem and confidence, and life 
skills training. OST is offered.
Prevention must be based on science, 
facts and best practices 
Prevention methods include environmental (wide 
reaching) focus on family, school and military environ-
ments. This includes a national science-based parent-
ing skills program; the integration of European Drug 
Prevention Quality Standards in preventive programs; 
science-based prevention interventions or programs 
in early childhood; legislation for a total ban on smok-
ing in schools; and web-based prevention programs. 
The EMCDDA also notes the greater attention needed 
for targeted prevention in Cyprus for high risk groups 
and the rare provision for development of personal 
and social skills.
The 2017-2020 Action Plan promotes targeted prevention 
as well as indicative prevention goals, offering support 
for vulnerable children and their families. NAAC currently 
funds 20+ evidence-based prevention programmes for 
vulnerable youth identified at community level as well 
as the school setting.
Data collection as a part of the right to 
access information for the community 
and the professionals
The central research funding organization is the 
Government (through the Cyprus National Addictions 
Authority (NAAC)). The NAAC seeks to provide relevant 
information to professionals and the community as 
well, through providing current research7.
Information is shared or provided at schools and 
in certain targeted communities concerning risks 
associated with drug use and the harmful use of 
alcohol. Information days at schools are rated as a 
7. Cyprus National Addictions Authority’s official website: https://
www.naac.org.cy/. 
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form of intervention with limited provision, though 
information on drugs without a focus on personal 
skills is considered to be in effect with full provision.
Rehabilitation and social reintegration
According to a report made for the Ministry of Health 
in Cyprus8, “detoxification, rehabilitation and relapse 
prevention are offered in the general addiction psy-
chiatry setting” and “THEMEA is no longer the only 
drug and alcohol detoxification and rehabilitation 
centre in the public sector in Cyprus”. 
Alcohol detoxification treatment is now offered by 
another service in the private sector. As regards to drug 
use detoxification there is ANOSIS, a government inpa-
tient detoxification service.
Social reintegration programmes are offered by various 
services, including Ayia Skepi residential rehabilitation 
service. In addition, NAAC is funding a social reintegration 
programme, offering vocational training and job opportu-
nities for service user of social reintegration programmes.
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc. 
The National Strategy on Illicit Substances Dependence 
and the Harmful use of Alcohol and related Action Plan 
seeks to provide treatment for groups such as migrants 
and women, though there is limited information on 
the progress of this goal.
Under the prevention pillar and the priority for the 
prevention of FAS/FASD and offering support for vul-
nerable children and affected children and families, 
NAAC developed clinical guidelines for professionals 
working with women and children, a guide for healthy 
lifestyles during pregnancy and the breastfeeding 
period, training for professionals aiming to enhance 
their knowledge and develop and identification 
mechanism for referral to treatment. 
NAAC also funds a programme offering prevention, 
harm reduction and treatment for migrants and refu-
gees at reception areas.
Fight against stigma and raising 
awareness in the society as a whole
Awareness raising is being done in Cyprus through 
research, targeted prevention and distribution of 
information on drug use in schools.
8. SAMARTZIS Lampros, “Advances in the treatment of sub-
stance use disorder in Cyprus”, BJPSYCH INTERNATIONAL, 2018, 
3 p. Available online: https://www.moh.gov.cy/MOH/MHS/mhs.
nsf/All/79B78052A143B8E1C22582BF003E1583/$file/advances_
in_the_treatment_of_substance_use_disorder_in_cyprus.pdf. 
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
In 2016, a law was passed where individuals under 
certain circumstances are permitted to seek alternative 
treatment to imprisonment. This excludes extreme 
felony and supply charges.
The main law regarding alternatives to punishment 
is the Law for the “Treatment of accused or convicted 
drug users or drug dependent individuals” which was 
approved by the House of Representatives in April 2016. 
This legislation also covers minors. Its name has since 
been changed (Law 57(Ι)/1992 for the “Treatment of 
accused drug users or drug depended individuals”) to 
exclude convicted persons, since there is no option of 
appeal for this group under the provisions of this leg-
islation, once the sentence has actually been passed.
The Protocol of Cooperation for the Referral of Young 
Offenders to the Treatment Centres that was devel-
oped between the Cyprus Police (Drug Law Enforcement 
Unit – D.L.E.U.), the Sovereign Base Areas Police and 
The Ministry of Health provides an alternative to pros-
ecution for young drug offenders arrested for the first 
time. Through their referral to therapeutic programs 
young people who use drugs are given the opportunity 
of an early intervention or a more intensive treatment 
programme, according to their needs.  The criteria for 
admission to the programme are:  
 ► Youths and young adults who have been arrested 
for the first time in connection with drugs cases;
 ► The seized quantity of drugs is such, as to be 
intended for personal use;
 ► The person is legally responsible, and he/she is 
aged 14 up to 24;
 ► The person has not committed any offence: At the 
time of investigation or arrest, immediately before 
or immediately after, the person has not committed 
any offence in breach of section 244 of the Criminal 
Code or at the time of his/her apprehension or 
arrest by the Police, his/her behaviour has not 
incited others to committing any criminal offences;
 ► The person will attend and complete a treatment 
program in one of the governmental or non-gov-
ernmental treatment centres. 
According to the protocol, in the case where a young 
offender meets the aforementioned criteria, the case does 
not proceed to a trial, provided the offender completes an 
eight hour long psychosocial intervention programme.
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
The NAAC is responsible for the accreditation, evalu-
ation and coordination of all programs, actions and 
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activities related to drug treatment, whether they are 
carried out by governmental services, non-govern-
mental organizations (NGOs) or the private sector. It 
may also provide some funding to these programs, 
actions and activities.
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
Harm reduction interventions in Cyprus aim to reduce 
the consequences of drug use in society through 
testing for infectious diseases. Furthermore, Cyprus 
plans to increase harm reduction through the referral 
of people in contact with emergency services after 
an overdose to treatment. 
Also, it has introduced take-home naloxone (nasal spray) 
and plans to introduce rapid tests for HIV, HBV and HCV 
at drug treatment centres. The personnel of drug treat-
ment centres have been trained for both these actions.
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
Harm reduction interventions in Cyprus aim to reduce 
the consequences of drug use in society through vac-
cinations and referral for treatment; disseminating 
information and providing education; and providing 
medical care whenever necessary. These services 
are provided by all governmental (and some non-
governmental) treatment programs.
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Egypt
T he main source of information for this country is the Council of Europe 2014 Report “Egypt: Drug situation and policy9”: any information not 
quoted as coming from another source is considered 
to come from this report. The MedNET Representative 
of Egypt, Prof. Menan Abd-El-Maksoud RABIE, was sat-
isfied with the information provided by the Secretariat. 
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
The current drug law substitutes the jail penalty for 
drug use by treatment (since 2018).
Additionally, according to Article 37 of the Egyptian 
Criminal Law, a convicted addict may be referred 
to a specialized facility for treatment rather than 
imprisonment.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
UNODC states, “A Middle East and North Africa network 
on drug dependence treatment is being developed 
and includes government counterparts, academic 
institutions, and treatment providers. Another focus is 
given to building bridges between legislative bodies 
and systems of healthcare, drug dependence treat-
ment, social services, vocational training, law enforce-
ment and criminal justice10.”
Prevention must be based on science, 
facts and best practices 
UNODC also states that “in Egypt, [the UNODC Regional 
Office for the Middle East and North Africa] (ROMENA) 
is working closely with the Ministry of Education, the 
Ministry of Social Affairs, the National Fund for Drug 
Control and Right Start Foundation International (NGO) 
to combat drug addiction in Egypt. The Youth Initiative 
9. Council of Europe, “Egypt: Drug situation and policy”, 2014, 
48 p. Ref: P-PG/MedNET (2014) 5. Available online: https://
rm.coe.int/drug-situation-and-policy-by-dr-dalal-abd-el-wahab-
general-secretary-o/168075f0e5.
10. United Nations Office in Drugs and Crime (UNODC), 
“Middle East and North Africa: Drug Prevention, Treatment 
and Rehabilitation”. Available online: https://www.unodc.org/
middleeastandnorthafrica/en/regional-programme-framework/
drug-prevention-and-health/drugs.html. 
has launched an awareness campaign that aims to 
spread knowledge with regards to the dangers of 
drug addiction11”.
Data collection as a part of the right to 
access information for the community 
and the professionals
The UNODC notes that they provide “training and 
technical assistance to selected countries for estab-
lishing drug information systems and building the 
capacity to access the availability, quality, coverage 
and impact of prevention, treatment and rehabilita-
tion interventions, using internationally harmonized 
indicators and tools12.”
Rehabilitation and social reintegration
Detoxification services, rehabilitation, observation 
unit and day care and after day care programs are 
available.
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc. 
Some goals of the national strategy include:
 ► Establishing and equipping prisons for those 
convicted & sentenced in drug crimes & offenses;
 ► Residential Treatment Programs for people who 
use drugs aim to provide services to treatment 
with “an open-door policy”;
 ► Mission to provide an effective, comprehensive, 
and developed variety of addiction treatment 
services that meet our clients’ needs, and to 
support their families.
Fight against stigma and raising 
awareness in the society as a whole
One of the main missions of Egyptian residential 
treatment programs for [people who use drugs] is to 
“inform the Egyptian society about addiction”.
11. United Nations Office in Drugs and Crime (UNODC), 
“Middle East and North Africa: Drug Prevention, Treatment 
and Rehabilitation”, Opus Citatum.  
12. Ibidem. 
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Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
Egypt has the Mental Health Act 71, which concen-
trates on the human rights issues of patients within 
psychiatric facilities, and on monitoring all processes 
and treatment procedures within the facilities.
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
There is funding for prevention and treatment of 
addiction: this funding represents one of the leading 
mechanisms for the implementation of the national 
programs for the prevention of smoking and drug 
[use], and for the support and provision of free treat-
ment and rehabilitation services for addicts, in col-
laboration with relevant partners.
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
No information found. 
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
No information found. 
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France
T he main source of information for this country is the EMCDDA 2019 Report “France: Country Drug Report 201913”: any information not quoted as 
coming from another source is considered to come 
from this report. The MedNET Representative of France, 
Ms. Laura D’ARRIGO, made comments in italics. 
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
Suspension of proceedings by the court before passing 
judgment (and, usually, conviction) is a mechanism 
available in many European countries. Normally with 
the consent of the offender, the court may require 
attendance at treatment. This suggests a potential 
move toward treatment instead of forms of punish-
ment or imprisonment for drug use.
Although the law provides for the possibility of prison 
sentences for drug use, account is taken when it is applied, 
of users’ circumstances and the question of addictions. 
Users are treated above all as citizens, not as crimi-
nals. The courts may ask users to agree to treatment or 
another procedure instead of going to trial. For persons 
most affected by addiction, an injunction to undergo 
therapy is possible.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
OST treatment is available in France, as well as pharma-
cologically assisted and psychosocial treatments. The 
Social Security system in France finances the provision 
of drug treatment. Outpatient and inpatient care are 
provided through CSAPAs [Centres for Care, Support 
and Prevention in Addictology] within France as well.
One of the particular features of France is that treat-
ment under the medical welfare system is guaranteed 
to be free of charge and anonymous. This applies, for 
instance, to drug consumption rooms. It is also the case 
with the two key addiction treatment facilities, namely 
the CSAPAs and the CAARUDs [Centres for Reception 
and Accompaniment for the Reduction of Risks for Drug 
Users], which are available throughout France.
13. European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), “France: Country Drug Report 2019”. 
Available online: http://www.emcdda.europa.eu/countries/
drug-reports/2019/france_en. 
There are also systems making it possible to provide 
optimum care for drug users, particularly through treat-
ment flats in CSAPAs or schemes such as “a place to call 
home”, through which homeless people suffering from 
addiction have access to housing. All the existing treat-
ments for addiction are available in France. In 2019, the 
Minister of Health published a roadmap for 2019-2022 
to prevent and combat opioid overdoses. This includes 
enhancing the accessibility of substitution treatment, 
involving users and their entourage and promoting 
co-ordinated grassroots activities.
France sets great store by harm reduction programmes. 
For instance, there are currently two drug consump-
tion rooms in France, one of which is in Strasbourg [the 
other one is located in Paris]. In particular, the Law of 
2016 afforded protection to the persons running such 
programmes. This means that persons working on harm 
reduction programmes are protected from prosecution 
for inciting or helping persons to use drugs. The law also 
broadened the scope of harm reduction programmes, 
extending them to cover the reduction of welfare risks 
in addition to health risks.
Prevention must be based on science, 
facts and best practices 
The new National Action Plan on Addictions 2018-22 
aims to roll out programmes for developing psychoso-
cial skills, contributing to a healthy school environment 
and the prevention of at-risk behaviour, including 
addictive behaviours.
Programmes based on psychosocial skills have been 
developed, particularly in schools. The examples of the 
GBG [Good Behaviour Game] programme in primary 
schools and the Unplugged programme at secondary 
level offer the possibility of providing seamless preven-
tion throughout school. 
The plan is for these two projects to be progressively rolled 
out throughout the country. Such projects are made 
possible by substantial State investment, particularly 
through the Fund to Combat Addictions.
The French drug addiction office, the OFDT, regularly 
publishes documents on drug user behaviour and mar-
ket trends which enable policy makers to gain a clear, 
up-to-date overview of drug issues and take decisions 
based on the latest scientific data.
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Data collection as a part of the right to 
access information for the community 
and the professionals
Data collection, such as surveys and research projects, 
are often funded by non-governmental organizations 
and foundations representing practitioners.
Additionally, the French Observatory for Drugs and Drug 
Addiction (OFDT) is the main body involved in drug-
related data collection, studies and network develop-
ment. It collaborates extensively with national and 
European drug-related research teams. Its mandate 
also includes the dissemination of data and research 
results, together with publishing results in national 
and international scientific journals and promoting the 
use of research findings in practice and policymaking.
The OFDT helps to promote the use of scientific data when 
policies are devised at national, European and interna-
tional level by working closely with the Interministerial 
Drug Addiction Task Force, MILDECA, acting as France’s 
focus point for the work of the EMCDDA and conducting 
studies on systems set up in other countries to combat 
addiction.
Furthermore, most of the OFDT’s work is published online, 
meaning that it is accessible to the public.
Rehabilitation and social reintegration
Frances Public Health Law of 2004 defines further 
public health priorities, such as providing referral to 
the care system, contributing to improving the health 
of people who use drugs and facilitating their social 
reintegration.
The French system seeks to facilitate reintegration into 
society for convicted [people who use drugs]. Convictions 
for drug use alone do not result in a criminal record that 
is accessible to the public. Only the authorities have 
access to the criminal registry on which it is permitted 
to enter convictions for drug use. In addition, convicted 
persons are always entitled to request that the courts 
remove convictions from the record so that they can 
pursue a career project.
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc. 
Drug treatment for prisoners is mostly provided 
through hospitals.
Specialized drug treatment centres are another key 
element of drug treatment within France.
Selective prevention mainly takes place in at-risk 
neighbourhoods for illicit drugs or in urban recre-
ational settings for alcohol. There is focus on children 
within the child welfare service and the judicial youth 
protection service.
The medical welfare system has adapted to the specific 
challenges which women face. For example, in some 
CAARUDs, particular time slots are reserved exclusively 
for women so that they can be given advice in a healthy 
and reassuring environment.
Since 1994 it has been guaranteed in law that prison-
ers will be treated equally to the rest of the population. 
Prisoners are treated in hospital and have social insur-
ance. Harm reduction and prevention for prisoners form 
part of the priorities of the National Plan to Combat 
Addiction for 2018-2022. Once again the State works 
with associations in this field and awards grants to the 
Narcotics Anonymous association for its work in prisons. 
This is also a part of the health plan for persons placed 
under judicial supervision.
Fights against stigma and raising 
awareness in the society as a whole
France has been rated by the EMCDDA to have level 
4, extensive provision of intervention in schools by 
providing information days on drugs, and rated level 
3, as having limited provision of intervention for devel-
oping social and personal skills. 
The National Action Plan against Addiction for 2018-2022 
places emphasis on the development of programmes 
based on psychosocial skills, particularly in schools.
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
The Law of 197014 states that “the use and possession 
of illicit drugs are criminal offences in France. The law 
itself does not distinguish between possession for 
personal use or for trafficking, or by type of substance.”
Punishments consist of up to 5 years and a fine, or 
10 years in specified aggravating circumstances. 
Sentences of up to life in prison and a fine of up to 7,5 
million Euros is possible for criminal groups engaged 
in drug trafficking.
Though it is also noted that in some circumstances, 
there is alternative to direct imprisonment: [people 
who use drugs] would continue to receive the thera-
peutic injunction directing them to treatment. If there 
are aggravating circumstances, such as recidivism, 
imprisonment may be imposed. This suggests some 
adaptation toward a human rights approach.
14. Act No. 70-1320 of 31 December 1970 on health measures 
to combat drug addiction and the suppression of trafficking 
in and illicit use of poisonous substances. Available online: 
https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORF
TEXT000000321402&categorieLien=id
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The rights of the accused are always respected. They are 
entitled to a fair trial, time limits on and judicial review of 
police custody and where they disagree with the penalty 
imposed on them, the right to appeal.
The law makes provision for numerous alternatives to 
prison adapted to each individual. For cannabis users 
who are not addicted, awareness-raising sessions on the 
dangers of cannabis are the courts’ initial response. Fines 
are also possible as an alternative to prison.
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
The authorities support consumer associations by means 
of grants. This is the case in particular with the associa-
tion ASUD, which is a drug users’ self-help group, or the 
association Techno+, which organises harm reduction 
at festive events. MILDECA also tries to disseminate 
prevention and harm reduction messages as widely as 
possible among party and festivalgoers, particularly by 
working with video directors on YouTube.
The French State does extensive work with civil society 
to combat addiction and improve drug users’ health.
In the context of the fund to fight addiction, the national 
call for projects for the “Mobilisation of Civil Society” in 
2019 was intended to support the implementation of 
campaigns run by civil society bodies. 
The goal was to support national projects pursuing the 
following purposes:
 ► Improving information and understanding, par-
ticularly among the general public or particular 
target audiences, elected representatives and 
opinion formers, about the impact and dangers of 
psychoactive substance use (particularly tobacco, 
alcohol and cannabis) and the benefits of stopping 
or reducing their use; 
 ► Deconstructing the commercial and marketing 
strategies of the tobacco, alcohol and/or can-
nabis industries;
 ► Making tobacco, alcohol and cannabis less com-
monplace in society, particularly among young 
people;
 ► Promoting the involvement of users or former 
users themselves (young people, peer helpers, 
expert patients, pregnant women, etc.), particu-
larly in projects to stop substance use and in harm 
reduction and/or advocacy projects; helping to 
equip or back up the work of health and social and 
educational support professionals in the spheres 
of preventing potentially harmful use of psychoac-
tive substances and harm reduction.
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
The Law of 201615 also broadened the scope of harm 
reduction programmes, which no longer focus solely 
on the reduction of health risks but also address 
welfare risks.
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
Harm Reduction strategy in France includes needle 
and syringe programs (NSPs), advice on safer drug 
use, and general health promotion activities.
Anonymous screening is also provided for (HIV), hepa-
titis B virus and hepatitis C virus (HCV).
The Fund to Combat Addictions linked to Psychoactive 
Substances set up by the Social Security Finance Law of 
28 December 2018 makes it possible to continue and step 
up anti-smoking campaigns and launch public health 
programmes dealing with other addictions, particularly 
alcohol and cannabis.
It contributes to the funding of national or local activities 
in keeping with government priorities where it comes to 
preventing addictions, particularly those deriving from 
the national anti-smoking programme and the national 
action plan against addiction.
These activities have 4 strategic goals:
 ► To protect young people and prevent them from 
taking up smoking as well as preventing them or 
delaying them from engaging in the use of other 
psychoactive substances;
 ► To help smokers to give up smoking and reduce 
the risks and damage caused by psychoactive 
substance use;
 ► To step up activities targeting certain priority 
groups out of a desire to reduce social inequalities 
in access to health services;
 ► To support applied research and a review of pre-
vention and care schemes.
In 2019, a budget of 120 million Euros was given over 
to enhancing action to combat addiction.
France sets great store by harm reduction programmes. 
The latest development was the establishment of two 
drug consumption rooms in France. The Law of 2016 
provides legal protection for the persons responsible 
for such programmes. This means that persons work-
ing on harm reduction programmes are protected from 
prosecution for inciting or helping persons to use drugs. 
15. Act No. 2016-41 of 26 January 2016 on the modernization of 
the health system. Available online: https://www.legifrance.
gouv.fr/affichTexte.do?cidTexte=JORFTEXT000031912641&cat
egorieLien=id. 
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Greece
T he main source of information for this country is the EMCDDA 2019 Report “Greece: Country Drug Report 201916 “: any information not quoted 
as coming from another source is considered to 
come from this report. The MedNET Representative 
of Greece, Mr. Gerasimos PAPANASTASATOS, was 
satisfied with the information provided by the 
Secretariat.  
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
Upon the order of the investigating judge, offenders 
may be admitted to a special treatment unit operating 
in a prison setting or a community drug treatment 
program operated by a lawfully recognized agency 
(the law specifies the recognized drug agencies).
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
Some forms of treatment offered within Greece 
include inpatient, psychosocial treatment, and OST 
treatment. Additionally, outpatient treatment is pro-
vided through specialized drug treatment centres 
and prison units.
Prevention must be based on science, 
facts and best practices 
Prevention methods in Greece include prevention of 
different kinds of dependency and the promotion of 
psychosocial health, school-based prevention inter-
ventions and anti-bullying policies.
Additionally, Prevention Centres provide training and 
support to teachers around program implementation. 
The development of personal and social skills is a key 
feature of these activities. Families are also a core 
target group; family prevention includes information 
events and training programs.
16.. European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), “Greece: Country Drug Report 2019”. 
Available online: http://www.emcdda.europa.eu/countries/
drug-reports/2019/greece_en. 
Data collection as a part of the right to 
access information for the community 
and the professionals
Several government sources provide funding for 
research, mainly to university departments and to a 
major treatment centre that is active in the research 
field.
Rehabilitation and social reintegration
No information found. 
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc. 
Selective intervention programs in Greece such as 
the Icarus Prevention Unit (KETHEA) for instance, 
designs and implements interventions aimed at young 
offenders, young people who experiment with drugs, 
immigrants, returning migrants, refugees, disabled 
children, children from dysfunctional environments, 
at-risk families and children living in care institutions.
Fights against stigma and raising 
awareness in the society as a whole
Prevention Centres for Addiction and Psychosocial 
Health Promotion provide information and raise public 
awareness about drugs and drug dependency, while 
prevention professionals target specific members of 
local communities, such as the army, public security 
forces, health professionals and youth mediators.
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
Greek drug law states that a drug-dependent offender 
charged with drug dealing can be considered for con-
ditional release, provided that, he or she has served 
a minimum of one fifth of the sentence and has suc-
cessfully and certifiably completed drug treatment.
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
No information found. 
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Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
Two drug treatment agencies, KETHEA and OKANA, 
focus on prevention of infectious diseases and of 
overdose deaths, as well as on the management of 
health problems among people who use drugs. People 
who use drugs attending a drug treatment program 
have the right to free medication if they are HIV or 
hepatitis C virus (HCV) positive or have other serious 
health problems.
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
Other methods used to reduce consequences of 
drug use include needle and syringe programs, 
printed health education and information materials, 
and training in safe use and first aid for drug users.
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Italy
T he main source of information for this country is the EMCDDA 2019 Report “Italy: Country Drug Report 201917”: any information not quoted as 
coming from another source is considered to come 
from this report. The MedNET Representative of Italy, 
Dr. Elisabetta SIMEONI, made comments in italics.   
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
If a person is found in possession of illicit drugs for 
the first time, administrative sanctions are not usually 
applied, but, instead, the offender receives a warning 
from the local Prefect and a formal request to refrain 
from use. A socio-rehabilitation and therapeutic pro-
gram may be offered in addition to administrative 
sanctions.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
Treatment methods in Italy include interventions car-
ried out by both public and private services include 
psychosocial support; psychotherapy and social ser-
vice interventions; detoxification in residential settings 
or hospitals; and vocational training in semi-residential 
settings.
OST, (public and private) inpatient and outpatient 
treatment services are available as well as mobile 
units, drop-in centres, reception units and outreach 
programmes.
Prevention must be based on science, 
facts and best practices 
In Italy the Life Skills Programme (Botvin) has been 
implemented and evaluated in Lombardy, with 
encouraging results. Available information shows 
that family involvement is considered central to all 
prevention efforts in Italy, and almost all regions have 
universal prevention projects targeting families, teach-
ers and peers.
17. European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA), “Italy: Country Drug Report 2019”. Available online: 
http://www.emcdda.europa.eu/countries/drug-reports/2019/
italy_en.
Data collection as a part of the right to 
access information for the community 
and the professionals
The Italian Action Plan recognises the importance 
of drug-related research, especially in the fields of 
neuroscience, neuroimaging, and behavioural, social 
and educational sciences. To this end, the Department 
for Anti-Drug Policies (DAP) supports the develop-
ment of an institutional scientific community. The 
outcomes of research are published both in national 
and international scientific journals.
Harm reduction strategy in Italy often consists of 
needle and syringe programmes (NSPs), information 
dissemination and counselling.
Rehabilitation and social reintegration
The majority of social-rehabilitative facilities are pro-
vided by private organizations. They provide inpatient 
treatment, but also semi-residential and outpatient 
treatment. Referral to social-rehabilitative facilities is 
made and paid for by the Ser.Ds (public drug depen-
dency service units).
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
Some programmes focus on particular groups, such 
as cocaine users, children and adolescents who use 
psychoactive substances, those with dual diagnosis, or 
members of ethnic minorities. Additionally, selective 
prevention activities also target immigrants, school 
dropouts, young offenders, families with problem 
drug use and/or with mental health problems, and 
socially and academically marginalized young people.
Fights against stigma and raising 
awareness in the society as a whole
Prevention activities are often implemented in schools 
by teachers, as well as by local health authorities, law 
enforcement agencies and private social agencies. 
They are mostly focused on information provision 
and awareness raising.
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Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
The Consolidated Law, adopted by Presidential Decree 
No 309 on 9 October 1990 and subsequently amended, 
provides the legal framework for the trade, treatment 
and prevention, prohibition and punishment of ille-
gal activities in the field of drugs and psychoactive 
substances.
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
No information found. 
Promoting the right to access treatment 
for all the consequences of drug use (such 
as AIDS, HIV, etc.) 
The right to health and the protection of health are 
defined as “a fundamental right of the individual” by the 
Italian Constitution (Article 32, paragraph I) and, for this 
reason, the Italian State guarantees free medical care to 
the indigent, including prisoners.
Furthermore, the Consolidated Law, adopted by 
Presidential Decree No 309 on 9 October 1990, defines 
that a drug user can turn to public services for drug addic-
tion or authorized private ones to undergo diagnostic 
tests and perform a therapeutic and socio-rehabilitation 
programs.
The 309/90 guarantees drug addict prisoners right to 
receive medical care and necessary assistance in prison 
institutions for rehabilitation purposes.
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
Harm reduction methods are provided through mobile 
units, drop-in centres, reception units and outreach 
programmes, and by public and private outpatient 
treatment services.
Additionally, harm reduction strategy in Italy often 
consists of needle and syringe programmes (NSPs), 
information dissemination and counselling.
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Jordan
T he main source of information for this country is the Council of the European Union’s “Regional Report on the Near East ‘CORDROGUE 86’18”: any 
information not quoted as coming from another source 
is considered to come from this report. The MedNET 
Representative of Jordan, Mr. Jamil ALHABAIBEH, 
was satisfied with the information provided by the 
Secretariat.  
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
According to an amendment on the Law on Drugs 
ratified by the Jordanian Parliament and published at 
the Official Gazette (2012), first time [people who use 
drugs] will be sent to a rehabilitation centre instead 
of prison.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
Strengthening the community resources in providing 
drug abuse treatment and rehabilitation for vulner-
able groups in Jordan” is a program implemented by 
the UNODC Office in Amman in cooperation with the 
Public Security Directorate (PSD) and the Jordanian 
Ministry of Health.
Prevention must be based on science, 
facts and best practices 
Prevention methods include school information pro-
grams on the dangers of drug use. Jordan continues 
to take measures to increase public awareness of the 
danger’ of drugs through an active awareness plan. 
The PSD/Anti-Narcotics Department (AND) conduct 
seminars and lectures at universities and schools, 
and distribute published material aimed at raising 
awareness. In addition, the AND’s awareness plan also 
involves cooperation with government institutions, 
NGOs, correction and rehabilitation centres, youth 
clubs and of course media.
18. Council of the European Union, “Regional Report on the 
Near East: ‘CORDROGUE 86’”, 17 December 2014 Available 
online: http://data.consilium.europa.eu/doc/document/
ST-13947-2015-INIT/en/pdf.
Data collection as a part of the right to 
access information for the community 
and the professionals
The Middle East and North Africa Harm Reduction 
Association (MENAHRA) promotes harm reduction 
through a network that revolves around three knowl-
edge hubs in the Islamic Republic of Iran, Lebanon and 
Morocco. The knowledge hubs cooperate via a net-
work secretariat. Each knowledge hub operates in part 
of the WHO Eastern Mediterranean Region, conducting 
advocacy, disseminating resources, providing training 
and supporting civil society organizations’ projects. 
According to a MENAHRA report on Harm reduction, 
“Soins Infirmiers et Développement Communautaire 
(SIDC)” is a resource centre which both collect and dis-
seminate information to the public on how to reduce 
harm associated with drug use. 
Rehabilitation and social reintegration
Rehabilitation in Jordan includes the aforementioned 
programme “Strengthening the community resources 
in providing drug abuse treatment and rehabilitation 
for vulnerable groups”.
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
Regional UNODC project entitled “Increasing Access 
to Prevention and Care Services for Drug Use and 
HIV/AIDS in the Prison Setting” is implemented by 
UNODC in cooperation with Jordanian PSD and the 
Ministry of Health.
Fights against stigma and raising 
awareness in the society as a whole
The Higher Council for Drug Awareness helps to raise 
awareness on drug related issues.
The Hashemite Kingdom of Jordan has continued to 
take measures in order to increase public awareness 
of the dangers of narcotics, through an effective and 
active plan in the field. They are visiting students in 
schools and Universities, lecturing and negotiating 
the dangers of drugs with the young generation of 
Jordanians.
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Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
The basic legislation is Law no. 11 of 1988 on Drugs 
and Psychotropic substances, as was amended around 
2014, distinguishing between first time users and 
long-term addicts. The amendment provides that first 
time users be placed in a rehabilitation centre instead 
of prison. However, due to a different reading of the 
term “first time users” between the Ministry of Justice 
and the Anti-Narcotics Department, an official inter-
pretation is awaited from the Prime Minister’s Office. 
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
SIDC in Beirut, Lebanon, is responsible for leading 
MENAHRA activities in Jordan. As an NGO with an 
established network in Lebanon and regionally, SIDC 
facilitated MENAHRA’s approach to civil society.
Moreover, the AND’s awareness plan also involves 
cooperation with NGO’s. 
Promoting the right to access treatment 
for all the consequences of drug use (such 
as AIDS, HIV, etc.) 
No information found. 
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
No information found. 
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Lebanon
T he main source of information for this country is the 2017 “National Report on Drug Situation in Lebanon19” coordinated by the Lebanese 
Ministry of Public Health (MOPH): any information not 
quoted as coming from another source is considered 
to come from this report. The MedNET Representative 
of Lebanon, Prof. Ramzi HADDAD, made comments 
in italics. 
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
According to Article 189 of the Drug Law, persons 
who earn a certificate of recovery will be exempted 
completely from legal pursuit. National Mental Health 
Programme at the MOPH, created the first national 
strategy for mental health and substance use.
Circular No. 76 of 22 August 2019, issued by MOPH urged 
all hospitals, health workers and health professionals to 
abide by other circulars confirming that cases of overdose 
on substances do not require the Internal Security Forces 
to be informed or any judicial action to be taken in this 
regard in order to preserve the patient’s right to health 
care and treatment, to respect the patient’s privacy and 
avoid stigma and discrimination against the patient.
Also, the Minister of Interior directed an official commu-
nication asking to inform all concerned internal security 
forces of the content of MOPH circular.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
MOPH reports that Services for persons with substance 
use disorders are provided by NGOs, private clinics and 
hospitals. Many of these NGOs are engaged in lobby-
ing and advocacy to increase treatment availability.
Additionally, NGOs providing specialized services in 
more than one location, most of them (around 80%) 
were located in Mount Lebanon and Beirut.
19. Ministry of Public Health of the Republic of Lebanon, 
“National Report on Drug Situation in Lebanon”, 2017. 
Available online: https://www.moph.gov.lb/userfiles/files/
Programs%26Projects/MentalHealthProgram/NODDA_2017_
english.pdf. 
Outreach, needle and syringe programs, voluntary 
counselling and testing centres, overdose prevention 
services, screenings, and other primary health care 
services are available. OST is also available, as well as 
outpatient and inpatient services.
When individuals are admitted for detoxification at 
the expenses of the Ministry of Public Health, they 
contribute with a small share to the cost of their 
detoxification (15%). They can access rehabilitation 
programs at no cost, the NGOs complementing the 
coverage of the Ministry of Social Affairs and provid-
ing additional coverage through donors and fund-
raising activities.
Prevention must be based on science, 
facts and best practices 
Various prevention programmes are being imple-
mented such as life skills or parenting skills educa-
tion, peer-to-peer education, and general awareness 
campaigns20.
In line with the “Inter-ministerial Substance Use Response 
Strategy for Lebanon 2016-2021”, strategic objective to 
pilot and explore the scale-up of evidence-based preven-
tion interventions for youth, the National Mental Health 
Programme (NMHP) at the MOPH organized training 
for trainers on “Line Up Live Up”, an evidence-informed 
training programme on life skills. Prior to the training, 
the “Line Up Live Up” (LULU) manual that was developed 
by UNODC was adopted and adapted to the Lebanese 
context. This evidence-informed manual aims to build 
the resilience of youth at risk, specifically using sports 
as a way to reduce risky behaviour, including harmful 
substance use, among young people aged 14-18 years 
living in adverse circumstances21.
20. Fonds des Nations unies pour l’enfance (UNICEF), “An 
evidence-informed life skills education programme tar-
geting youth at risk in Lebanon”, July 2019. Available 
online: https://www.unicef.org/lebanon/press-releases/
life-skills-education-programme.
21. Ministry of Public Health, Ministry of Education and Higher 
Education, Ministry of Interior and Municipalities, Ministry of 
Justice, and Ministry of Social Affairs 2016, “Inter-Ministerial 
Substance Use Response Strategy for Lebanon 2016-2021”, 
Version 1.1 Beirut: Lebanon. Available online: https://www.
moph.gov.lb/userfiles/files/Inter-minsiterial%20Substance%20
Use%20Response%20Strategy%20for%20Lebanon%20
2016-2021-V1_1-English.pdf.
Page 34 ► Human Rights and people who use drugs in the Mediterranean Region: current situation in 17 MedNET countries
Data collection as a part of the right to 
access information for the community 
and the professionals
MEHE, MOSA and MOPH collaborate with NGOs to 
regularly disseminate an up-to-date list of evidence-
based community-based prevention interventions to 
all relevant actors.
Rehabilitation and social reintegration
Treatment and rehabilitation programs for persons 
with drug use disorders are usually multi-disciplinary 
and use more than one approach such as: abstinence, 
Cognitive Behavioural Therapy (CBT), OST and other 
harm reduction interventions, faith-based and thera-
peutic community.
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
A qualitative research report on “Needs of women 
with substance use disorders” was coordinated and 
published by the MOPH in 201922. 
Methods of prevention in Lebanon include: 
“Conducting capacity-building activities for staff in 
social development centres and collaborating with 
NGOs in organizing preventive activities. The fol-
lowing programs were implemented in 2016: youth 
movement program, life skills development program, 
parents’ awareness and education programs, and 
youth awareness workshops. 
Lebanon’s Inter-Ministerial Substance Use Response 
Strategy objectives are:
 ► To ensure the development of a sustainable 
system for substance use response that guaran-
tees the provision of and universal accessibility 
to a full spectrum of high-quality gender and 
age sensitive prevention, treatment, rehabilita-
tion, harm reduction and social re-integration 
services;
 ► The strengthening of supply reduction interven-
tions, through a cost-effective, evidence-based 
and integrated multidisciplinary approach, 
with an emphasis on community involvement, 
continuum of care, human rights and cultural 
relevance. 
To finish with, a harm reduction awareness cam-
paign targeting prison inmates including women 
22. Ministry of Public Health (MOPH), “Needs of women with 
Substance Use Disorders”, Beirut: Lebanon, 2019. Available 
online: https://rm.coe.int/2019-needswomen-sud-lebanon 
-eng/168093ed80.
and juveniles in 14 prisons, in collaboration with the 
National Aids Program (NAP), ISF, UNODC and two 
implementing partners was set up.
Fights against stigma and raising 
awareness in the society as a whole
In order to raise awareness in society, the Internal 
Security Forces engage with NGOs in organizing 
awareness seminars and training of trainers.
Additionally, information is shared in efforts to educate 
the public in school settings, family and parenting skills 
training, vocational training and income-generating 
support.
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
[Drug] Law (Articles 199-204) requires from the 
Ministry of Public Health to establish or adopt detoxi-
fication facilities to treat persons with drug use dis-
orders, as well as psychosocial clinics to treat them 
for their psychological dependence.
Additionally the [Drug] Law provides the possibility 
for persons arrested for drug use with the option 
to be referred to a ministerial committee, the Drug 
Addiction Committee (DAC), which has the authority 
to offer the person the option of treatment or sanc-
tion, before, during or after sentence (Articles 183, 
189 and 198). Pursuit can be dropped if the person 
voluntarily presents in front of the DAC (Article 183).
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
A very limited number of self-help and mutual aid 
groups exist in Lebanon. Two groups affiliated to 
the international self-help movements Alcoholic 
Anonymous and Narcotics Anonymous are known to 
be established. Objective 2.1.18 of the Inter-ministerial 
strategy is set to “Facilitate the establishment of self- 
help and mutual aid groups” in 202123. 
23. Ministry of Public Health, Ministry of Education and Higher 
Education, Ministry of Interior and Municipalities, Ministry of 
Justice, and Ministry of Social Affairs 2016, “Inter-Ministerial 
Substance Use Response Strategy for Lebanon 2016-2021”, 
Version 1.1 Beirut: Lebanon. Available online: https://www.
moph.gov.lb/userfiles/files/Inter-minsiterial%20Substance%20
Use%20Response%20Strategy%20for%20Lebanon%20
2016-2021-V1_1-English.pdf
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Promoting the right to access treatment 
for all the consequences of drug use (such 
as AIDS, HIV, etc.) 
An addiction treatment plan, which targeted 665 
inmates, as well as prevention from and early diag-
nosis of HIV, hepatitis B and C targeted 1180 inmates, 
and prevention, diagnosis and treatment of sexually 
transmitted infections targeted 1214 inmates.
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
No information found. 
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Malta
T he main source of information for this country is the EMCDDA 2019 Report “Malta: Country Drug Report 201924 “ any information not quoted as 
coming from another source is considered to come 
from this report. The MedNET Representative of Malta, 
Prof. Marilyn CLARK, made comments in italics. Her 
main source of information is the EMCDDA report 
mentioned above and the National Report on the 
Drug Situation in Malta – 2019 National Focal Point 
for Drugs and Drug Addiction.
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
On the 15th of April 2015, the Government introduced an 
act to provide for the treatment of persons in possession 
of small quantities of prohibited drugs for personal use 
and for other measures for the rehabilitation of persons 
suffering from drug dependence.
The illegal use of psychotropic and narcotic drugs is not, 
per se, recognised in Maltese law, although the use of 
these substances, if proven in court, leads to a conviction 
for possession or trafficking. Maltese law recognises two 
kinds of possession: simple possession, or possession for 
personal use; and aggravated possession, or possession 
of drugs not for the offender’s exclusive use.
Under the Drug Dependence (Treatment not 
Imprisonment) Act 2014, a person found in possession 
of a small amount of drugs for personal use is tried in 
front of the Commissioner of Justice in an attempt to 
divert them from the criminalising impact of contact 
with the Criminal Justice System. To this effect a first 
offence is punishable through a fine. Any offender who 
commits a second offence within a period of 2 years is 
required to attend the Drug Offenders Rehabilitation 
Board, where he or she is assessed for drug dependence 
and any necessary order may be issued. In the case of 
an offender who commits a limited number of offences 
as a result of drug dependence, the Court may assume 
the function of a Drug Court and refer the offender to 
the Drug Offenders Rehabilitation Board.
This new legislation was an extension of a diversionary 
project proposed by the National Commission on the 
Abuse of Drugs, Alcohol and other Dependencies in 2012 
24. European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), “Malta: Country Drug Report 2019”. 
Available online: http://www.emcdda.europa.eu/publications/
country-drug-reports/2019/malta_en.
that aimed to divert first time offenders away from the 
criminal justice system towards some form of intervention. 
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
The Maltese National Drugs Policy (2008) streamlines 
the actions of the government and non-government 
bodies responsible for delivering services to drug users 
by seeking to improve the quality and provision of drug-
related services and aiming to promote health, well-being 
and social cohesion. It also highlights the cooperation 
between service providers and other health and social 
professionals and institutions to ensure a multidisci-
plinary approach to treatment provision.
Treatment in Malta includes: specialised outpatient 
services; low-threshold services; inpatient treatment 
programmes; detoxification treatment; and OST.
NGO-based outpatient services offer long- or short-term 
support through social work, counselling, group therapy, 
and psychological interventions, while low-threshold 
programmes offer day-care services.”
OAT is provided by the Substance Misuse Outpatient Unit 
(SMOPU). Methadone maintenance treatment has been 
available in Malta since 1987, with take-home metha-
done prescriptions available since 2005. Buprenorphine 
was introduced in 2006. It is also available as a take-
home treatment by prescription from either SMOPU or 
a general practitioner. Dihydrocodeine is prescribed in 
rare instances.
The Government committed itself to the construction 
of a new centre to provide interventions for minors that 
will house a maximum of 20 adolescents. 
Prevention must be based on science, 
facts and best practices 
School-based programmes primarily focus on the 
development of life skills such as enhanced self-
esteem, the ability to resist peer pressure and decision-
making and on increasing young people’s abilities 
to express their feelings and encouraging problem-
solving skills. Universal family-based prevention pro-
grammes in an interactive environment generally 
tackling topics related to parenthood, such as leader-
ship styles, communication and child development.
Few interventions are subjected to rigorous and 
scientific evaluation. 
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Data collection as a part of the right to 
access information for the community 
and the professionals
Both the government and university departments 
play an important role in undertaking research, which 
is mainly funded by the public sector. Drug-related 
research findings are disseminated by the national 
focal point through regular meetings with partners, 
direct mailing to interested parties, the media and on 
the national focal point website.
The introduction of the Master of Science in Addiction 
Studies as a joint initiative between the Faculty of Social 
Wellbeing and the Faculty of Medicine and Surgery in 
2019 is expected to reasonably increase the number of 
scientific studies on drug use on the Maltese islands. This 
evidence can then be fed into the policy cycle.
Rehabilitation and social reintegration
Five inpatient units are available in Malta, of which 
three are therapeutic communities. The residential pro-
grammes provide a holistic, multidisciplinary approach 
to therapy in a communal living environment, and 
attempt to guide clients towards abstinence. 
A National Audit was conducted by the National Audit 
Unit in 201225: “NAO noted that programmes specifi-
cally dedicated at addressing reintegration into society 
from an employment perspective were generally limited 
across the various service providers. Nonetheless, Caritas’ 
practice of assigning an employee, albeit on a part-time 
basis, to organise suitable training for residents, pro-
vide assistance in job seeking, and subsequently follow 
up when actually in employment is commended. The 
other service providers also delivered similar support 
functions; however, these were less formal in terms of 
design and delivery.”
The Rehabilitation In Society Malta Foundation (RISe)26 
started providing a reintegration service for prisoners, 
many of whom are substance abusers. The service is 
based on the principles of Restorative Justice. The service 
will continue to work with the Corradino Correctional 
Facility and prepare offenders for re-integration in soci-
ety. As a result of this re-integration the rate of recidivism 
is expected to decrease therefore enhancing the general 
public safety.
Access to treatment and care for specific 
populations: people who use drugs in 
25. Malta National Audit Office (NAO), “Performance Audit: 
Tackling Problem Drug Use in Malta”. Available online: http://
www.emcdda.europa.eu/system/files/attachments/5286/
National%20Audit%20O ffice%20%282012%29%20
Performance%20audit%20-%20Tackling%20problem%20
drug%20use%20in%20Malta.pdf.
26. https://maltacvs.org/voluntary/rehabilitation-in-society-2/
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
The Leap Project27 aims to consolidate community 
resources and networks to address social exclusion 
issues. Other target groups are young people in 
schools in deprived areas, juvenile prison inmates 
and young offenders. Aġenzija Appoġġ28, the national 
agency for children, families and the community, and 
Sedqa have brought together professionals from 
several fields to develop a project that aims to offer 
individual guidance and counselling to adolescents 
who are referred for support as well as their parents 
and partners. The unit also offers crisis intervention 
when homelessness or abuse is involved.
A special harm reduction centre for women who [use] 
drugs is operated by Caritas and provides sheltered 
accommodation and intensive therapy to clients 
who cannot achieve abstinence in the short term. 
Protection from different forms of violence and from 
involvement in sex work is also provided.
To finish with, Malta has developed a specific answer 
towards people who use drugs in prisons. 
According to the most recent data, in 2014 around 43 % 
of prisoners in Malta had a history of drug use prior 
to imprisonment and one quarter had been in drug 
treatment.
On entering prison, inmates undergo medical screening, 
which is followed by a consultation with the psychosocial 
team. Substance use problems are usually assessed with 
standardised tools. On admission, all prisoners are also 
tested for human immunodeficiency virus and hepatitis 
B virus (HBV) infections.
Most prisoners undergoing drug treatment in prison 
receive opioid agonist treatment (OAT). OAT is initiated 
at a hospital’s forensic unit and the inmates are trans-
ferred back to prison once they are stable. Additionally, 
there are protocols for the transfer of inmates to selected 
drug rehabilitation units. Drug treatment agencies offer 
counselling and support services to inmates inside the 
prison, including assistance with social reintegration. 
Since 2007, a vaccination programme for HBV has been 
in place.
Activities are undertaken to prepare inmates for release, 
but it is not within the remit of the prison to provide 
continuity of care.
Fights against stigma and raising 
awareness in the society as a whole
Raising awareness methods include discussions on 
drug and alcohol misuse through local councils, 
youth organizations, religious societies and social 
27. https://fsws.gov.mt/en/leap/Pages/default.aspx
28. https://fsws.gov.mt/en/appogg/Pages/overview-appogg.aspx
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and political clubs. Community and church activities, 
drug awareness talks, exhibitions, concerts and drug-
free activities are organized at specific times of the 
year and are aimed at the general public.
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
The conservative and punitive approach of the past was 
abandoned and substituted by a more lenient legisla-
tion that centres its focus around the victim’s treatment.
The Drug Dependence Act (treatment not imprison-
ment) is one form of a human rights approach in Malta.
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
There are five main drug treatment providers: three 
are funded by the government and two are non-
governmental organisations (NGOs) partially funded 
by the government.
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
Harm reduction methods include access to clean 
injecting equipment (Needle and Syringe programs 
are also available), testing and counselling for infec-
tious diseases such as human immunodeficiency virus 
(HIV), hepatitis B virus (HBV) and hepatitis C virus 
(HCV), risk awareness and HBV vaccinations. Blood 
screening and counselling for infectious diseases are 
provided at the substance misuse outpatient unit, in 
prison and at the sexual health clinic.
Needles and syringes are distributed at seven fixed loca-
tions across the country. In 2017, around 316 000 syringes 
were distributed through these specialised facilities, 
showing a decrease for the second consecutive year. This 
perhaps coincides with the registered decrease in inject-
ing behaviour among individuals in treatment. A special 
harm reduction centre for women who inject drugs is 
operated by Caritas and provides intensive therapy to 
clients who cannot achieve abstinence in the short term 
as well as sheltered accommodation.
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
Maltese National Drugs Policy adopted in 2008 is to 
achieve a high level of health protection and social 
cohesion by preventing and reducing drug-related 
harm to health and society, ultimately promoting a 
culture that discourages the use of illicit drugs.
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Morocco 
T he main source of information for this coun-try is the EMCDDA’s website page “Kingdom of Morocco country overview29”: any informa-
tion not quoted as coming from another source is 
considered to come from this report. The MedNET 
Representative of Morocco, Prof. Jallal TOUFIQ, made 
comments in italics. 
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
This approach is present in all the national action plans 
since 2009.
In Moroccan Law, it is possible to be referred to treat-
ment in lieu of, or in addition to, alternative punish-
ment or sentence for drug use30. This indicates a shift 
toward considering drug use rightly as a medical 
condition. 
The National Strategy Against Addiction notes goals 
to treat addiction, through development of facilities 
and training of human resources.  
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
Treatment methods in Morocco include inpatient 
and outpatient services, detoxification, psychosocial 
care, therapy, as well as other science-based methods. 
There also are private treatment centres and 4 University 
affiliated treatment centres. NGOs are involved in harm 
reduction programs and outreach. 
Treatment centres are available and accessible in all 
major cities of the country. All the public centres affili-
ated to the Ministry of Health (16 centres) are free of 
charge. Patients’ data are confidential, guidelines and 
treatments are science-based.
The National Centre for Addiction Treatment, 
Prevention and Research in Rabat-Salé is accessible 
29. European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA), “Kingdom of Morocco country overview”. Available 
online: http://www.emcdda.europa.eu/countries/
morocco_en.
30. Council of Europe, “Morocco: Drug situation and policy”, 2014, 
36 p. Ref: P-PG/MedNET (2014) 16. Available online: https://
rm.coe.int/drug-situation-and-policy-by-dr-maria-
sabir-university-hospital-ar-raz/168075f2a3.
to all Moroccans regardless of their geographic origins 
and has 16 inpatient beds for males and six for females.
Prevention must be based on science, 
facts and best practices 
Prevention is a major axis of all the national action plans; 
NGOs are involved in prevention and science-based 
trainings for professionals are available.
“Schools also play an important role in prevention 
through prevention activities, club, information ses-
sions as well as other initiatives within the framework 
of drug [use] prevention31.
Data collection as a part of the right to 
access information for the community 
and the professionals
The Ministry of Health has recently launched vari-
ous projects (such as REMAD, the Moroccan Network 
of Professionals, which was set up in 2019) to create 
an integrated data collection system that would 
facilitate data gathering and reporting for national 
and international purposes. The Treatment Demand 
Indicator protocol is being considered for adaptation 
and implementation in Morocco. All the reports made 
by the National Observatory on Drugs and Addictions 
are available for the general population.
Rehabilitation and social reintegration
Detoxification, aftercare and rehabilitation are pro-
vided through specialized addiction centres. Moreover, 
some treatment programs offer rehabilitation and some 
NGOs offer rehabilitation and social support.
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
The Ministry of Health plays a role in prevention in 
promoting targeted actions for young people, adults 
and vulnerable groups, with a significant focus on the 
implementation of a social communication strategy. 
8 treatment programs and 5 OAT programs exist for 
prisons. Specific treatment programs free of charge are 
available for migrants with mental conditions including 
addictions. 
31. Ibidem.
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Fights against stigma and raising 
awareness in the society as a whole
Awareness raising is done in schools through programs 
that seek to inform youth of the risks of drug use. 
Raising awareness campaigns in the general population 
are carried out at a regular basis.
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
1974 Law allows judges to refer to treatment centres 
users in possession of drugs for their own use.
Article 8 of law No. 1-73-28232 takes into account inter-
ests [of people who use drugs] as it does acknowledge 
the importance of treatment and care of narcotics 
addict. Criminal prosecution will not be brought if 
the author of the crime, following a medical exam 
performed at the request of the Royal Prosecutor, 
consents to go into treatment for drug addiction 
for as long as it is needed. Additionally, for minors, 
Article 8 states that treatment should be provided in 
a family setting, and in conformity with the conditions 
determined by order of the Minister of Justice made 
after consulting with the Ministry of Health. However, 
it is noted that this law is rarely applied in practice.
32. Ibidem.
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
NGOs of people who use drugs already exist in Morocco. 
They are generally very active in developing harm reduc-
tion interventions and outreach actions. They are funded 
by national and international organizations and sup-
ported by the Ministry in charge of the Civil Society. 
Self-support groups for AA and NA are available.
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
Specific HIV and HC treatment packages for people 
who use drugs are available. Harm reduction strategy 
includes opioid substitution treatment (OST), which 
is part of the National Risk Reduction Programme, 
as well as methadone maintenance treatment and 
needle and syringe programs. 
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
The range of services provided by harm reduction 
facilities includes distribution of injection kits and 
collection of used needles and syringes, distribution 
of condoms, awareness raising and education, and 
social support. Significant achievements’ through 
harm reduction have been noted.
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Palestine*
T he main source of information for this coun-try is the UNODC report “Illicit Drug Use in Palestine33”: any information not quoted as com-
ing from another source is considered to come from 
this report. The MedNET Representative of Palestine, 
Dr. Saed BALIBISI, made comments in italics. His main 
source of information is the National Palestinian Drug 
Control Program and the Palestinian Ministry of Health 
Anti-drug Strategy. 
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
People who use drugs in Palestine stressed the need 
to change perceptions and the stigma against drug 
users, and also to encourage law enforcement services 
to offer protection and treatment for people who use 
drugs and to convict drug dealers. 
A new National Palestinian Drug Control & Crime 
Prevention Program was set up by the Palestinian Anti-
Drug National in which it is considered that: 
 ► Drug addiction is a chronic disease;
 ► People who use drugs have the right for treatment, 
education, after-care, rehabilitation and social 
reintegration in conformity with paragraph 1 of 
Article 38.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
Mental health services in Palestine include addiction 
and drug abuse treatment but are still limited and 
confined to specific areas. Those services are provided 
by the Palestinian Ministry of Health (MOH) the pri-
vate sector, NGOs and the United Nations Relief and 
Works Agency. 
The MOH initially opened the Methadone Treatment 
Centre for  [people who use heroin] based in Ramallah 
city, working as secondary health facility since May 2014.
The centre includes psychiatry specialists who provide 
regular service for [people who use heroin] in addition 
to general practitioners, nurses, psychologists, as well 
as pharmacy and laboratory services.
33. United Nations Office on Drugs and Crime (UNODC), “Illicit 
Drug Use in Palestine” (November 2017). Available online: 
https://www.unodc.org/documents/publications/Illicit_Drug_
Use_in_Palestine.pdf.
In May 2018, the MOH also opened the Palestinian 
National Rehabilitation Centre based in Bethlehem, 
which provides tertiary care to all forms of addictions 
(heroin, cocaine, cannabis, alcohol, etc.).
All services are provided for free; patients do not need to 
have any health insurance to have access to the services.
Prevention must be based on science, 
facts and best practices 
The Anti-Narcotics Department runs prevention pro-
grams through which it promotes awareness in coordi-
nation with other organizations and provides capacity 
building for [drug use] treatment. The Caritas Old City 
Counselling Centre conducts training workshops for 
psychologists, social workers, and students on preven-
tion and intervention against drug abuse. The National 
Drug Control & Crime Prevention Program strategy men-
tions a goal for raising public awareness in cooperation 
with the MOI and MOH Education Department. Those 
programs target high schools refugees’ camps and civil 
councils in villages’ vulnerable areas (areas beside Israeli 
boarders and check points).
A plan for creating a hot line for people who use drugs 
to provide them with free consultation and information 
is now under discussion. 
To finish with, the MOH and MOI are now conducting 
workshops, meetings with students, the general public 
and patients in order to raise awareness on prevention 
and harm reduction – this issue is addressed on televi-
sion and radio stations. 
Data collection as a part of the right to 
access information for the community 
and the professionals
The Maqdese for Society Development publishes 
publications and studies addressing the problem of 
illicit drug use in Palestine.
Rehabilitation and social reintegration
Maqdese has established the Rehabilitation and 
Guidance Centre that offers psychological support, 
treatment and awareness services for people who 
use drugs.
The Palestinian National Rehabilitation Centre in 
Bethlehem and the Methadone Treatment Centre in 
Ramallah are providing rehabilitation services and inte-
grating people who use drug in communities.
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Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
The GCMHP (which provides comprehensive mental 
health services) in Gaza caters to men, women and 
children and addresses issues related to illicit drug use, 
including generic laboratory services for the diagnosis 
of addiction and community-based programming 
approaches to address drug use.
The UNODC states that in every three people who use 
drugs in Palestine are women, however, in Palestine, 
treatment is more limited for females than for males 
because of cultural expectations and the lack of treat-
ment services designed to meet the special needs of 
females.
In Jerusalem, Maqdese has also implemented special 
camps that train youth in Shufat refugee camp on 
leadership skills, decision-making, communication 
skills, and drug-related awareness. 
The MOH started the harm reduction program in the 
PNRC and The Methadone Centre, including the fol-
lowing objectives: 
 ► Universal:
 – Ensures universal access and continuity of care 
to all young people;
 – Aims to identify and screen those who are 
vulnerable to substance misuse and identify 
those to refer on; 
 – Identification of risks or child protection issues. 
 ► Fights against stigma and raising awareness 
in the society as a whole:
Since its establishment, the Anti-Narcotics Department 
has succeeded in identifying and stopping hundreds 
of drug trafficking and drug abuse cases and has 
organized hundreds of awareness sessions on the 
dangerous impact of drug use.
The Caritas Old City Counselling Centre organizes 
awareness sessions about drug dependency at schools 
in East Jerusalem and the West Bank.
The MOH, MOI, MOJ and MOE are conducting programs 
to reduce the stigmatization and providing privacy to 
people who use drugs. They also try to raise awareness 
amongst people who use drugs concerning their rights. 
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
When abusers of drugs have committed such offenses, 
the Parties may provide, either as an alternative to con-
viction or punishment or in addition to conviction or 
punishment, that such abusers shall undergo measures 
of treatment, education, after-care, rehabilitation and 
social reintegration in conformity with paragraph 1 of 
Article 38. 
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
 ► The National Palestinian Drug Control Program 
is studding this issue to be allowed;
 ► Self-support groups for AA and NA are available.
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
Maqdese provides harm reduction methods. 
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
 ► Targeted:
 – Youth orientated services, offered by practitio-
ners with some drug and alcohol experience 
and youth specialist knowledge;
 – Aim and purpose of this tier is to be concerned 
with reduction of risks and vulnerabilities and 
maintenance of young people in mainstream 
services.
 ► Specialist:
 – Work with complex cases requiring multidis-
ciplinary teamwork;
 – Deal with complex and often multiple needs 
of the C/YP and not just with the particular 
substance misuse;
 – Includes substitute prescribing;
 – Work towards reintegrating and including the 
child in their family, community, school or place 
of work. 
 ► Inpatient: 
 – Provides very specialist forms of intervention for 
people who use drugs with complex care needs; 
 – For a very small number of people, there is 
a need for intensive Interventions; this could 
include short-term substitute prescribing, 
detoxification and places away from home;
 – Care away from home might be offered such 
as residential units, enhanced fostering, and 
supported hostels. 
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Portugal
T he MedNET Representative of Portugal, Ms. Sofia SANTOS, has completely revised this sec-tion. Her main source of information is the 
Statistical Bulletin 2018 – Illicit Substances published 
by SICAD34 in 2019: any information not quoted as 
coming from another source is considered to come 
from this report.  
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
The Portuguese policy follows a public health 
approach, as drug use is considered a health prob-
lem, being a chronic relapsing disease and the people 
who use drugs needing care and not punishment. The 
National Strategy adopted in 1999 advocated for a 
change of law, drug addiction was to be viewed as 
a disease and drug users as citizens in need of treat-
ment and not as criminals. The Decriminalisation Law, 
which entered into force in 2001, implemented this 
approach: according to this Law, “a person caught 
using or possessing less than the maximum amount 
of a drug for personal use, where there is no suspicion 
of involvement in drug trafficking, will be evalu-
ated by the local Commission for Dissuasion of Drug 
Addiction, composed of three members, two being 
medical doctors, psychologists, sociologists or social 
workers and the third being a legal expert. Punitive 
sanctions can be applied, but the main objectives are 
to explore the need for treatment and to promote 
healthy recovery35.”
The Dissuasion model lies on the collaboration with 
drug treatment, harm reduction and social reintegra-
tion services, which provide for measures in a non-
judgmental and non-discriminatory way. 
34. General Directorate for Intervention on Addictive 
Behaviours and Dependencies (SICAD), Statistical 
Bulletin 2018 – Illicit Substances. Available online: 
http://www.sicad.pt/EN/Publicacoes/Paginas/detalhe.
aspx?itemId=165&lista=SICAD_PUBLICACOES&bkUrl=BK/
Publicacoes/.
35. European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA), Portugal: Country Drug Report 2019; “Drug 
laws and drug law offences”. Available online: http://www.
emcdda.europa.eu/countries/drug-reports/2019/portugal/
drug-laws-and-drug-law-offences_en.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
The National Plan for the Reduction of Addictive 
Behaviours and Dependencies 2013-20 states that 
treatment interventions should be:
 ► Based on a comprehensive diagnosis of each 
citizen’s full biopsychosocial needs;
 ► Accessible and adaptable;
 ► Based on scientific evidence in terms of effec-
tiveness, efficiency and quality; 
 ► Supported by guidelines.
The public services are provided free of charge and 
are accessible to all people who use drugs and who 
seek treatment.
Healthcare for [people who use drugs] was re-
organised in Portugal in 2013-14, being provided 
accordingly with the Referral Network for Addictive 
Behaviours and Dependencies. The network encom-
passes public specialised services of treatment for 
illicit substance dependence, under the authority of 
Regional Health Administrations of the Ministry of 
Health, NGOs and other public or private treatment 
services interested and competent in provision of 
care. The network incorporates three levels of care: 
(i) primary healthcare services; (ii) specialized care, 
mainly in outpatient settings; and (iii) differentiated 
care, mainly in inpatient settings (detoxification units, 
therapeutic communities, day centres and/or special-
ized mental or somatic health care)36. The network 
ensures wide access to quality-controlled services 
provided through several treatment modalities and 
in integration with other, non-health, services, to this 
vulnerable population.
Prevention must be based on science, 
facts and best practices 
The Portuguese National Plan frames the preventive 
intervention for the Reduction of Addictive Behaviours 
and Dependencies 2013-2020 (PNRCAD), that calls 
for the need of promotion of preventive interven-
tions, taking into account evidence and best practices. 
The measures developed have been based on the 
operational levels of universal, selective and indicated 
36. European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA), Portugal: Country Drug Report 2019; “Treatment”. 
Available online: http://www.emcdda.europa.eu/countries/
drug-reports/2019/portugal/treatment_en.
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prevention, taking into account the diagnosis of vul-
nerability and risk factors evaluated at territorial level37. 
Prevention actions and intervention programs are 
developed in different settings for different target 
groups, both from the broader perspective of health 
promotion and with a specific focus on aspects of 
addictive behaviours and dependencies, as particularly 
institutional tutelary and educational; recreational 
settings; school; armed forces, workplace; National 
Alcohol and Health Forum (FNAS) and the national 
telephone helpline “Linha Vida – SOS Droga”.
Data collection as a part of the right to 
access information for the community 
and the professionals
“SICAD uses its website, reports, national scientific 
journals, scientific meetings and seminars as its main 
dissemination channels for drug-related research find-
ings. A list of national scientific publications (scientific 
papers, reports and academic theses) in the areas of 
illicit drugs, alcohol and addictive behaviours was 
established in 2017 and is regularly updated.38”
SICAD manages the National Information System on 
Drugs and Addictive Behaviours, being responsible 
for the collection, analysis and dissemination of sta-
tistical and epidemiological data on drug use. The 
System includes surveys, as well as general popula-
tion, younger and specific groups data from public 
services, private entities and NGOs. 
A report about the country on drugs and drug addic-
tions and the harmful use of alcohol is presented 
annually to the National Parliament.
Rehabilitation and social reintegration
Portugal prioritizes a comprehensive, integrated 
approach that systematically addresses the multiple 
barriers faced by drug users, like human, social and 
economic components. The approach focuses on the 
needs of the individual, his characteristics and personal 
resources, and on the degree of dependence of psy-
choactive substances and other addictive behaviours. 
The development of integrated strategies to mediate 
the reconciliation between the individual and the 
social systems, trying to provide for measures in terms 
of housing, education, training and employment is 
essential for drug users or recovering drug users to re-
establish their individual balance and gain autonomy. 
Reintegration is considered to be part of a complete 
37. EMCDDA, Ibidem, “Prevention”. Available online: http://www.
emcdda.europa.eu/countries/drug-reports/2019/portugal/
prevention_en.
38. EMCDDA, Ibidem, “Drug-related research”. Available online: 
http://www.emcdda.europa.eu/countries/drug-reports/2019/
portugal/drug-related-research_en.
treatment process, as the process of integration of 
individuals seeking support in specialized services, 
starting at the first contact with the request for help, 
and is maintained until the person gains indepen-
dence and stability by integrating, as a citizen with 
rights and duties, the society in which they live. 
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
The National Health Service is free of charge and 
accessible to all, including people who use drugs, 
who seek treatment and the responses defined for 
each target group. Even though there are specific 
interventions/programmes for specific populations.
In accordance with the legislation in force (the person 
imprisoned is a user of the National Health Service), 
health care should be ensured as any other citizen 
in an appropriate and timely manner by the safe-
guarding health organism. Thus, the health strategy 
for prisons is aligned with the strategy and national 
policies, conducting the general standards of good 
medical practices like those practiced in the National 
Health Service.
The referral to treatment in encouraged in the prison 
setting, as is ensured to all new inmates the continuity 
of pharmacological treatments initiated in freedom 
and encourages the referral to the different responses 
of existing treatment in prisons. Specifically, in the 
context of the treatment of addictive behaviours and 
dependencies two types of programs are available: 
abstinence-oriented programs and pharmacological 
programs. The first includes 6 drug-free units inserted 
in prisons. Pharmacological programmes can be pro-
vided internally in each prison when this has enabled 
clinical staff or by the national Health System. All 
prisons establishments have health care provision 
in the valences in General Medicine and Nursing; the 
provision of others (Psychiatry, Medicine, Dentistry, 
Psychology, Genecology, Pharmacy) is different tak-
ing into account, inter alia, the size and degree of 
complexity of the establishment and specificity of 
the inmate population.
Within the National Network of Treatment, all out-
patient settings:
The Centres of Integrated Responses (CRI) propose 
specific dispositions for pregnant women and/or with 
children, involving also their relatives and significant 
others. These dispositions cover a wide range of the 
treatment process, from priority in accessing first con-
sultation and admission to treatment programmes, 
to specific interventions involving their drug and 
other related bio-psycho-social problems, referral 
to specialised health care, linkage to social support 
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and rehabilitation measures. There are also in place 
therapeutic communities which can receive pregnant 
women and/or with children. 
Long-standing dispositions regarding access and deliv-
ery of treatment to undocumented persons make that 
migrants and/or asylum seekers may benefit from the 
full scope of public treatment responses, without any 
sort of discrimination or limitation. Along with treat-
ment for their addictive problems, in the Centres of 
Integrated Responses they will also find the possibility 
of concomitant support to deal with their juridical and 
social situation, provided by the Social Reintegration 
Specialised Teams operating in these facilities.
Fights against stigma and raising 
awareness in the society as a whole
The first Portuguese National Strategy on Drugs 
approved in 1999, was based on 8 Principles, among 
which the Humanism and Pragmatism. The citizen 
is the centre of the conceptualization of the policy 
and interventions based on the assumption that it is 
fundamental to respond to the needs of individuals, 
as early as possible. Drug addiction was perceived 
as a disease and people who use drugs as citizens in 
need of treatment. 
The Law 30/2000, which entered into force 1 July 
2001, introduced a radical change in the way of facing 
drug use and defines the legal framework applicable 
to the consumption, acquisition and possession for 
own consumption of narcotics and psychotropic sub-
stances. The main purpose of the Law is the dissuasion 
of the consumption and the basic concern has been 
to give priority to treat offenders rather than applying 
sanctions (better to send a drug addict for treatment 
than to prison). The non-existence of criminal record 
for the drug users notified to appear in front of the 
CDT is another key element to combat stigma.
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
Law 30/2000 decriminalized consumption, acquisition 
and possession of drugs for personal consumption and 
defined a threshold for the personal consumption of 
10 days, this element being decisive for police authori-
ties to address the person as drug user (notification 
to the Dissuasion Commission) or as trafficking user 
(criminal justice system). Drug user is perceived a 
person in need of care and treatment and not as a 
criminal.
Children under the age of 16 years are considered 
unimpeachable (article 19 of the Penal Code). The 
legal regime applicable to young people between the 
ages of 12 and 16 is included in the Education Law. 
The purpose is to re-educate, avoiding the negative 
consequences of a criminal conviction identical to that 
of an adult. Although the decriminalisation law applies 
to all individuals with more than 16 years of age, in 
practical terms there are some differences concerning 
procedures in the operationalization of the law. Young 
minors between the ages of 16 and 18 (who are inca-
pacitated on grounds of age) must be accompanied 
by their legal representatives, when appearing at the 
Commissions for the Dissuasion of Drug Addiction 
(CDT). In cases where the police authorities have not 
notified the legal representatives, the CDT has to do 
it. From the age of 18, the individuals are considered 
adults, assuming full criminal and civil responsibility 
for their actions. The minimum age to be referred to 
a CDT is 16 years old.
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
The State does not fund the creation and daily man-
agement of NGOs. Under the Operational Plan For 
Integrated Responses (PORI), integrated interventions 
implemented at local level by NGOs could be financed 
by SICAD. In Portugal, there is CASO (Consumidores 
Associados Sobrevivem Organizados), a non-profit 
drug user and former user’s association that aims to 
promote the health, rights and dignity of people who 
use drugs and which work focus is on peer education 
(on-site) with harm reduction approach.
The National Council for Drug Problems, Drug 
Addiction and the Harmful Use of Alcohol is the consul-
tative body of the Prime Minister and the Government 
on policies related to drugs, drug addiction and the 
harmful use of alcohol, being responsible for issuing 
opinions on the definition and implementation of 
key programmatic instruments, in particular on the 
National Strategy and Action Plans; on the annual 
report on implementation of the National Strategy 
and on actions, initiatives or concrete projects for 
their implementation.
The National Council is composed of representatives 
from 23 public and private institutions, including 
NGOs. 
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
Universal, comprehensive and free treatment is avail-
able in outpatient and inpatient settings in, as well 
as in outreach programmes through mobile units.
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Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
A nationwide network of harm reduction programmes 
and structures has been put in place, including primary 
care health centres, needle and syringe exchange 
programmes, low-threshold substitution programmes, 
a mobile supervised drug consumption unit, drop-in 
centres/shelters, refuges, contact units and outreach 
teams, has been consolidated with the aim of prevent-
ing drug-related risks such as infectious diseases, social 
exclusion and delinquency.
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Spain
T he main source of information for this country is the EMCDDA report “Spain: Country Drug Report 201939”: any information not quoted as coming 
from another source is considered to come from this 
report. The MedNET Representative of Spain, Ms. 
Elena ALVAREZ MARTIN, made comments in italics. 
Her main source of information is the website of the 
Spanish Ministry of Health’s National Plan on Drugs40. 
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
Spain has an approach to the drug problem based on 
public health principles, so drug use is a public health 
problem and thus people who use drugs are not treated 
as delinquents, but as sick people41.
In the criminal field, drug use and possession for self-
consumption is not considered as a crime. In the admin-
istrative field, public drug use and possession, for self-
consumption, is an administrative offense punished 
with fines.
There are circumstances where treatment, rehabilita-
tion or counselling services can act as an alternative 
to punishment or act as a supplementary part of an 
individual’s sentence.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
Outpatient treatment is most common in Spain; OST as 
well as inpatient detoxification are available. Inpatient 
treatment is fully available when needed or when the use 
is problematic42. In the web page of the DGPNSD, there 
is a georeferencial tool43 to locate Centres for Addictions 
Treatment all over Spain.
39. European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), “Spain: Country Drug Report 2019”. 
Available online: http://www.emcdda.europa.eu/countries/
drug-reports/2019/spain_en.
40. Spanish Ministry of Health, National Plan on Drugs official 
website: http://www.pnsd.mscbs.gob.es/home.htm. 
41. Spanish Ministry of Health, National Plan on Drugs official 
website, “Legislación”:  http://www.pnsd.mscbs.gob.es/ciudada-
nos/legislacion/home.htm. 
42. Spanish Ministry of Health, Memoria: Plan Nacional Sobre 
Drogas 2017. Available online: http://www.pnsd.mscbs.gob.
es/pnsd/memorias/docs/2019_MEMORIA_2017.pdf. 
43. Spanish Ministry of Health, National Plan on Drugs official 
website, “Centros de Atención a las Adicciones”: http://www.
pnsd.mscbs.gob.es/ciudadanos/ayudaCerca/home.htm. 
Prevention must be based on science, 
facts and best practices 
Activities include psychosocial attention and develop-
ment of psychoeducational skills. There are increas-
ingly more alternative leisure programs of selective 
prevention focused on minors in high-risk situations.
The National Strategy on Addictions 2017-2024 has 
among its principles that its actions have to be evidence-
based, efficient, realistic and quantifiably promoting 
best practices44.
Data collection as a part of the right to 
access info for the community and the 
professionals
The Spanish Observatory on Drugs and Addictions 
(OEDA) collects, analyses and disseminates statistical 
and epidemiological data on drug use, and the surveys 
as well as general population, youngers, and specifics 
(prison, occupational). 
OEDA also manages a Centre of Documentation 
Information (CENDOCU), which collects, selects and 
disseminates information related to addictions, as well 
as answer request for documentation.
National scientific journals and specialized websites are 
the main channels for national dissemination of drug-
related research findings.
Rehabilitation and social reintegration
Support apartments for treatment and social reinte-
gration are sometimes a part of inpatient treatment.
In Spain, a wide variety of social reintegration pro-
grams and activities are also available, including (i) 
leisure and social relationship programs, (ii) train-
ing programs, (iii) residential support programs and 
resources (both transitory and permanent) and (iv) 
employment grants.
Access to treatment and care for specific 
populations: people who use drugs in 
44. Spanish Ministry of Health, Estratégia Nacional Sobre 
Adicciones 2017-2024. Available online:  http://www.pnsd.mscbs.
gob.es/pnsd/estrategiaNacional/docs/180209_ESTRATEGIA_N.
ADICCIONES_2017-2024__aprobada_CM.pdf. 
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prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
Selective prevention activities focus on young people 
in disadvantaged neighbourhoods and those in spe-
cific educational or residential centres.
Fights against stigma and raising 
awareness in the society as a whole
Prevention programs in universities have emerged in 
recent years and focus mainly on information provision 
and awareness raising, using peer education methods 
or online delivery.
Rated as level 4, extensive intervention for information 
days about drugs and development of personal and 
social skills is provided by the EMCDDA45.
National Strategy on Addictions 2017-24 is articulated 
around two major goals: (i) a healthier and better-
informed society and (ii) a more secure society.
Law adaptation to the human rights 
approach especially for minors and non-
trafficking users
In Spain, consumption or minor personal possession 
in public places is deemed a (non-criminal) order 
offence, punishable by fines (Law on the Protection 
of Citizens’ Security (2015), Article 36). 
If the offenders are minors (over 14 to 18), the fine 
imposed on them may be suspended, initially, and 
partially cancelled, later, if they voluntarily submit to 
treatment, rehabilitation or re-education programmes 
are available (Additional Provision Five of Organic Act 
nº 4/2015)46.
Promoting the right of people who use 
drugs to create their own NGOs and self-
help groups
NGOs are a key part of the National Drug Plan. Their work 
in the fight against addictions enriches and complements 
the work developed by the different Administrations and 
the scientific community47.
45. Spanish Ministry of Health, Estratégia Nacional Sobre 
Adicciones 2017-2024. Available online:  http://www.pnsd.mscbs.
gob.es/pnsd/estrategiaNacional/docs/180209_ESTRATEGIA_N.
ADICCIONES_2017-2024__aprobada_CM.pdf. 
46. Spanish Ministry of Health, National Plan on Drugs official 
website, “”Legislación”: http://www.pnsd.mscbs.gob.es/ciu-
dadanos/legislacion/home.htm. 
47. Spanish Ministry of Health, National Plan on Drugs official 
website, “Entidades del Tercer Sector que participan en el Plan 
Nacional sobre Drogas”: http://www.pnsd.mscbs.gob.es/pnsd/
entidadesTercerSector/home.htm. 
Spanish Council of Drug Dependencies and other 
addictions48: Collegiate body of a technical, consulta-
tive, coordination and participation nature, attached 
to the Ministry of Health, Consumer Affairs and Social 
Welfare through the Government Delegation for the 
National Drug Plan, which brings together not only 
various representatives of all public administrations 
with powers in the field of drug use reduction and the 
State Attorney General’s Office, but also to an important 
representation of the main social agents involved in the 
prevention and treatment of addiction-related problems.
It develops its activities through working groups. 
Nowadays there are 6: health, social integration, occu-
pational integration, third sector, communication and 
gender perspective. In all the groups participation of 
civil society and academia experts are fundamental.
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
In Spain, most harm reduction programs include a 
socio-sanitary service that offers preventive educa-
tional interventions, clean needles and syringes and 
other paraphernalia, testing for drug-related infec-
tions, vaccination against hepatitis A and B viruses, 
and emergency care and assistance for people who 
use drugs, who are not usually in contact with any 
assistance intervention.
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
The Drugs Care Centres take care of any kind of addic-
tions licit (alcohol abuse) or illicit (substances) as well 
as behavioural addictions (gambling, new technologies 
end others) in every autonomous communities and cities. 
There are other kinds of programmes (such as residential 
and capacity programmes) and training for occupational 
and live skills, work itineraries and active job search. 
48. Spanish Ministry of Health, National Plan on Drugs official 
website, “Consejo Español de Drogodependencias y otras 
adicciones”: http://www.pnsd.mscbs.gob.es/delegacionGobi-
ernoPNSD/organigrama/funciones/consejo.htm. 
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Switzerland 
T he main source of information for this coun-try is the Swiss Federal Act on Narcotics and Psychotropic Substances49: any information not 
quoted as coming from another source is considered 
to come from this report. The MedNET Representative 
of Switzerland, Ms. Diane STEBER BÜCHLI, made com-
ments in italics. 
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
According to Transform: Drug Policy Foundation, “In 
1991, at the request of municipal authorities and 
state (canton) governments, a new national program 
was established within the Federal Office of Public 
Health to reconsider the problems. Reflecting previ-
ous experiences, the recommendations that emerged 
were public health-led, including a combination of 
established harm reduction interventions (OST and 
NSP), treatment and social support provision, and a 
new call to explore HAT. In 1992, a change in the law 
enabled such an exploration50.”
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
Federal Act on Narcotics and Psychotropic Substances, 
Art. 3.d.: “The cantons* shall ensure the supervision 
of persons with disorders associated with addiction 
who require the medical or psycho-social treatment 
or welfare measures.”
*In Switzerland, the policy is developed on a national 
(federal) level, but the implementation lies within the 
competence of the cantons (regions, states).
Prevention must be based on science, 
facts and best practices 
The cantons shall promote education and advice on 
the prevention of disorders associated with addiction 
49. Federal Council – The Portal of the Swiss Government, 
Federal Act on Narcotics and Psychotropic Substances. 
Available online: https://www.admin.ch/opc/en/classified-
compilation/19981989/index.html.
50. Transform: Drug Policy Foundation’s official website, “Heroin-
assisted treatment in Switzerland“: https://transformdrugs.
org/heroin-assisted-treatment-in-switzerland-successfully-
regulating-the-supply-and-use-of-a-high-risk-injectable-drug/.  
and their negative health-related and social conse-
quences. In doing so, they shall pay special attention to 
the protection of children and adolescents. They shall 
introduce adequate general conditions and create the 
required facilities or support private institutions that 
meet the quality requirements.
Data collection as a part of the right to 
access info for the community and the 
professionals
The Confederation shall inform cantons and private 
organizations of new scientific findings – hence keep 
track of what the latest developments are. 
Also, it is responsible for training and quality assurance. 
Federal Act on Narcotics and Psychotropic Substances, 
Art. 3. f.: “The authorities and institutions responsible for 
the implementation of this Act are entitled to process 
personal data, and in particular sensitive personal data 
and personality profiles in order to review the require-
ments for and the progress with the treatment of persons 
dependent on narcotics.
They shall guarantee the protection of data (…)
The Federal Council shall regulate the details, in par-
ticular: (…)
d. the rights of access.”
Rehabilitation and social reintegration
Federal Act on Narcotics and Psychotropic Substances, 
Art. 3.d.: “The treatment is carried out with the aim of 
guaranteeing the therapeutic and social integration 
of persons with disorders associated with addiction, 
improving their physical and psychological health and 
creating conditions in which they can live a drug-free 
life.
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
First, the country has universal health care, so everyone 
has health insurance. Then, they are obliged to provide 
treatment services, see Federal Act on Narcotics and 
Psychotropic Substances, Art. 3. d.
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Fights against stigma and raising 
awareness in the society as a whole
The Confederation shall conduct national programs 
on prevention and in particular encourage the early 
recognition of disorders associated with addiction; 
in doing so, it shall prioritize the concerns relating to 
the protection of children and adolescents. It shall 
raise public awareness of the problems of addiction.
Federal Act on Narcotics and Psychotropic Substances, 
Art. 3. j.: “The Confederation  (...) support scientific 
research [in the field of] preventive and therapeutic 
measures and the prevention or reduction of disorders 
associated with addiction.”
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
According to Transform, “the change in policy and 
law, much like the introduction of decriminalisation 
approaches in other countries, has helped facilitate 
(a) shift51.” 
Due to the situation on hand in the ‘90s in the country, 
there was a shift in the legal approach concerning 
people who use drugs and this shift focuses more on 
“human rights”, though not directly mentioning them.
51. Transform: Drug Policy Foundation’s official website, “Heroin-
assisted treatment in Switzerland“: https://transformdrugs.
org/heroin-assisted-treatment-in-switzerland-successfully-
regulating-the-supply-and-use-of-a-high-risk-injectable-drug/.  
Promoting the right of people who use 
drugs to create their own NGOs and self-
help groups
No information found.
Promoting the right to access treatment 
for all the consequences of drug use (such 
as AIDS, HIV, etc.) 
No limitation to medical treatment and obligatory health 
insurance for all residents, including groups such as 
asylum seekers.
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
In order to prevent or reduce health-related and social 
harm among persons with disorders associated with 
addiction, the cantons shall introduce harm reduction 
and survival support measures. They shall create the 
required facilities or support private institutions that 
meet the quality requirements*.”
*Those are the driving factors; the others are not consid-
ered reasons for harm reduction measures.
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Tunisia
T he main source of information for this country is the Council of Europe 2014 Report “Tunisia: Drug Situation and Policy52”: any information not 
quoted as coming from another source is considered 
to come from this report. The MedNET Representative 
of Tunisia, Prof. Nabil BEN SALAH, made comments 
in italics. 
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
Act 92-52 of the 1992 Narcotics Act aimed to “intro-
duce the following provisions: the establishment 
of a national drug observatory to collect data; the 
establishment of treatment centres, including the 
introduction of substitution therapy; the diversion 
of first and second-time offenders arrested for use, 
to social services (third-time offenders will serve the 
same terms as the current law provides, between 
one and five years); and the possibility for judges to 
decide on the most appropriate sentences53.” These 
changes indicate a shift toward seeing drug use as a 
medical condition. 
Treatment to be available, accessible, 
affordable and science-based, with the 
best practices
There are treatment programs and facilities within 
Tunisia, as well as specialized treatment centres in 
some hospitals, inpatient treatment, and other forms 
of medical care. 
Prevention must be based on science, 
facts and best practices 
“Prevention efforts by the UNODC in prisons work to 
inform and reduce spread of HIV/AIDS, Hepatitis, STI, 
52. Council of Europe, “Tunisia: Drug situation and policy”, 2014, 
36 p. Ref: P-PG/MedNET (2014) 12. Available online: https://
rm.coe.int/drug-situation-and-policy-by-pr-hajer-aounallah-
skhiri-medecin-epidemi/168075f2a4.
53. TINASTI Khalid, “Cannabis and the Drug Law in Tunisia: A 
Reform Rooted in Social Justice Claims”, Global Drug Policy 
Observatory Situation Analysis, Swansea University Publications, 
April 2018, 7 p. Available online: https://www.swansea.ac.uk/
media/Cannabis-and-the-Drug-Law-in-Tunisia-A-Reform-
Rooted-in-Social-Justice-Claims.pdf. 
as well as providing treatment, care and additionally 
aiding in reintegration of inmates54.”
Additionally, there are “prevention campaigns in 
schools, both public and private, across the country, in 
an effort to promote a sense of responsibility amongst 
at-risk groups, especially young people.”
Data collection as a part of the right to 
access info for the community and the 
professionals
The National Narcotics Bureau of the Ministry of 
Health in Tunisia participates in healthcare educa-
tion by presenting prevention and educational mate-
rial designed to combat addiction, based on reports 
communicated by relevant bodies subordinated to 
the Ministry of Public Health and authorities in charge 
of combating the illegal use of narcotics and psycho-
tropic substances.
Rehabilitation and social reintegration
Sfax Rehabilitation Centre and Jebel Oust Rehabilitation 
Centre (Ministry of Health) seek to help Tunisian youth 
suffering from addiction in an effort to help their 
recovery by providing medical care and assisting their 
rehabilitation into Tunisian society.
(Ministry of Health, ATUPRET, ATIOST, ATL MST Sida as 
well as other organizations, have similar objectives in 
Tunisia). 
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
ATUPRET works to bring awareness activities aimed 
at target groups and voluntary and free of charge 
screening as well as awareness and involvement of sex 
workers in community activities and the distribution 
of prevention kits.
54. United Nations Office in Drugs and Crime (UNODC), 
“Middle East and North Africa: Drug Prevention, Treatment 
and Rehabilitation”. Available online: https://www.unodc.org/
middleeastandnorthafrica/en/regional-programme-framework/
drug-prevention-and-health/drugs.html. 
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Fights against stigma and raising 
awareness in the society as a whole
ATUPRET, ATIOST, ATL MST Sida are organizations 
in Tunisia that raises awareness and educate young 
people on the risks and consequences related to 
drug use. 
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
In Tunisia, “Chapter IV of Law 52 deals with health 
care and the prevention of drug use. It provides that 
a person using drugs will not face prosecution if, 
before law enforcement authorities discover his deeds, 
he voluntarily seeks treatment at a state rehabilita-
tion centre. This exemption applies only to first-time 
offenders55.”
Bill 79, Act 92-52 of the 1992 Narcotics Act on the 
criminalization/decriminalization of use and pos-
session of drugs in Tunisia, states: “any consumer or 
holder of narcotics who has not agreed to medical, 
psychological or social treatment, or to be placed 
under medical supervision in a health establishment 
as provided for in Article 13 of this Act, or who has 
abstained from or interrupted treatment56.” The idea 
of treatment here acts as a move toward human rights 
adaptation to law in Tunisia. 
55. Human Rights Watch, “‘All this for a joint’: Tunisia’s Repressive 
Drug Law and a Roadmap for Its Reform”, February 2016. 
Available online: https://www.hrw.org/report/2016/02/02/
all-joint/tunisias-repressive-drug-law-and-roadmap-its-reform. 
56. TINASTI Khalid, “Cannabis and the Drug Law in Tunisia: A 
Reform Rooted in Social Justice Claims”, Opus Citatum. 
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
No information found.
Promoting the right to access treatment 
for all the consequences of drug use (such 
as AIDS, HIV, etc.) 
There is a project for harm reduction that aims “to pro-
mote human rights-based, gender responsive, public 
health-centred, and evidence-based approaches and 
to build the capacities of government officials and 
civil society organizations to deliver a comprehensive 
package of HIV/AIDS services in prisons and closed 
settings57.”
Moreover, risk reduction programs in Tunisia including 
MENAHRA, promote needle exchange programs, coun-
selling IDUs and other methods of harm reduction.  
Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
No information found.
57. United Nations Office in Drugs and Crime (UNODC), 
“Middle East and North Africa: Drug Prevention, Treatment 
and Rehabilitation”. Available online:https://www.unodc.org/
middleeastandnorthafrica/en/regional-programme-framework/
drug-prevention-and-health/drugs.html. 
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Turkey
T he main source of information for this country is the EMCDDA report “Turkey: Country Drug Report 201958”: any information not quoted as 
coming from another source is considered to come 
from this report. The MedNET Representative of Turkey, 
Mrs. Yasemin ESEN, was satisfied with the information 
provided by the Secretariat. 
Health approach at the policy level:  
drug use being considered rightly as a 
medical condition to be taken by qualified 
care health professionals 
No punishment will apply if a dependent user requests 
treatment before investigation; in such cases, health-
care professionals are not obliged to report the offence.
Treatment to be available, accessible, 
affordable and science-based,  
with the best practices
Drug treatment programmes aim to help clients 
achieve a drug-free state. An essential part of the 
treatment is detoxification, which is complemented 
by other interventions consisting of motivational 
interviewing techniques and cognitive therapies that 
aim to prevent relapse. Pharmacological treatment 
with opioid agonists or an antagonist is also available.
Additionally, there is OST available. Up to 80 % of OST 
medication costs are covered by general health insur-
ance; clients contribute the remaining 20%.
Prevention must be based on science, 
facts and best practices 
Prevention interventions targeting young people 
are also supported by non-governmental organisa-
tions. The methods used include counselling support, 
seminars, discussion panels and conferences. Manual-
based programs are rare.
Data collection as a part of the right to 
access info for the community and the 
professionals
Information sessions in school settings are available. 
58. European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), “Turkey: Country Drug Report 2019”. 
Available online: http://www.emcdda.europa.eu/countries/
drug-reports/2019/turkey_en.
Rehabilitation and social reintegration
Some treatment centres provide short-term residential 
treatment, and some non-governmental organisations 
provide treatment communities.
Access to treatment and care for specific 
populations: people who use drugs in 
prisons, sex workers, pregnant women, 
migrants, refugees, elderly, etc.
Some selective prevention interventions focus on 
awareness-raising and information provision, while 
Social Services Centres provide some social assistance 
and referrals to treatment institutions for homeless 
children and young people.
Fights against stigma and raising 
awareness in the society as a whole
Some family-oriented prevention projects are carried 
out in cooperation with school counselling centres. 
At the community level, prevention activities are 
mainly informative.
Law adaptation to the human rights 
approach especially for minors and  
non-trafficking users
There is an option of treatment and/or probation of 
up to 3 years.
If people who use drugs refuse treatment or do not 
comply with their probation requirements, the courts 
can impose a prison sentence. 
Promoting the right of people who use 
drugs to create their own NGOs and  
self-help groups
No information found.
Promoting the right to access treatment 
for all the consequences of drug use  
(such as AIDS, HIV, etc.) 
No needle and syringe programmes, take home nal-
oxone programs, drug consumption rooms, or heroin-
assisted treatment reported as available. 
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Promoting every strategy aiming at 
reducing the health, economic, social and 
legal consequences of drug use
No information found.
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The Council of Europe is the continent’s leading 
human rights organisation. It comprises 47 member 
states, including all members of the European 
Union. All Council of Europe member states have 
signed up to the European Convention on Human 
Rights, a treaty designed to protect human rights, 
democracy and the rule of law. The European Court 
of Human Rights oversees the implementation 
of the Convention in the member states.
For the first time, the Mediterranean Network for cooperation on 
drugs and addictions of the Pompidou Group discussed human 
rights. This started with a first literature research covering different 
topics. Among them, the consideration of drug use as a disease for 
developing drug policy, the right to access to care and treatment as 
a fundamental right for people who use drugs, the implementation 
of evidence-based prevention practices and health strategies, the 
fight against stigma and the needed adaptation of the law to a 
human rights approach. 
Research was carried out among the 17 MedNET countries (Algeria, 
Croatia, Cyprus, Egypt, France, Greece, Italy, Jordan, Lebanon, 
Malta, Morocco, Palestine*, Portugal, Spain, Switzerland, Tunisia 
and Turkey). Better understanding the meaning of human rights in 
drug policy and exchange best practices and ideas on this subject, 
was the objective of this first exercise, to be repeated.
